AU607101B2

AU607101B2 – Photoprotection compositions comprising tocopherol sorbate
– Google Patents

AU607101B2 – Photoprotection compositions comprising tocopherol sorbate
– Google Patents
Photoprotection compositions comprising tocopherol sorbate

Download PDF
Info

Publication number
AU607101B2

AU607101B2
AU24083/88A
AU2408388A
AU607101B2
AU 607101 B2
AU607101 B2
AU 607101B2
AU 24083/88 A
AU24083/88 A
AU 24083/88A
AU 2408388 A
AU2408388 A
AU 2408388A
AU 607101 B2
AU607101 B2
AU 607101B2
Authority
AU
Australia
Prior art keywords
composition
skin
exposure
tocopherol sorbate
ethylhexyl
Prior art date
1987-10-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU24083/88A
Other versions

AU2408388A
(en

Inventor
Donald Lynn Bissett
Rodney Dean Bush
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Procter and Gamble Co

Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-10-22
Filing date
1988-10-21
Publication date
1991-02-21

1988-10-21
Application filed by Procter and Gamble Co
filed
Critical
Procter and Gamble Co

1989-04-27
Publication of AU2408388A
publication
Critical
patent/AU2408388A/en

1991-02-21
Application granted
granted
Critical

1991-02-21
Publication of AU607101B2
publication
Critical
patent/AU607101B2/en

2008-10-21
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K8/00—Cosmetics or similar toiletry preparations

A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition

A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds

A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds

A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K8/00—Cosmetics or similar toiletry preparations

A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition

A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds

A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds

A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom

A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K8/00—Cosmetics or similar toiletry preparations

A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition

A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds

A61K8/67—Vitamins

A61K8/678—Tocopherol, i.e. vitamin E

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K8/00—Cosmetics or similar toiletry preparations

A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition

A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds

A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds

A61K8/89—Polysiloxanes

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K8/00—Cosmetics or similar toiletry preparations

A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition

A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof

A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P3/00—Drugs for disorders of the metabolism

A61P3/02—Nutrients, e.g. vitamins, minerals

Abstract

Disclosed are pharmaceutical compositions comprising tocopherol sorbate which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of tocopherol sorbate and sunscreening agents are also disclosed. Also disclosed is a method for using these compositions topically, to prevent damage to skin caused by acute or chronic UV exposure.

Description

COMMONWEALTH OF AUSTRALIA Fo r PATENTS ACT 1952-6 COMPLETE SPECIFICATION
(ORIGINAL)
Class Int. Class Application Number: Lodged: Complete Specification Lodged: Acceptdh Published: Priority Related Art: Name of Applicant Addruss of Applicant Actual Inventor: Address for Service THE PROCTER GAMBLE COMPANY One Procter Gamble States of America Plaza, Cincinnati, Ohio 45202, United DONALD LYNN BISSETT AND RODNEY DEAN ‘JKH EDWD. WATERS SONS, 50 QU2EN STREET, MELBOURNE, AUSTIALIA, 3000.
Complete Specification for the invention entitled: PHOTOPROTECTION COMPOSITIONS COMPRISING TOCOPHEROL SORBATE The following statement Is i full description of this hiwention, Including the best method of performing It known to US 1) insert DATE of Vm V/J I. signin (mi v Silat»s) o Richard Charles Witte (declim Ass.i.stant-..Secr.tar…….
other t To: The Commissioner of Patents I PHOTOPROTECTION COMPOSITIONS COMPRISING TOCOPHEROL
SORBATE
&Dnnz is-u±±i i’y TECHNICAL FIELD This invention relates to topical compositions useful for protecting the skin from the harmful effects of ultraviolet irradiation, such as sunburn and sun-induced premature aging of the skin.
BACKGROUND OF THE INVENTION Sunbathing is a popular activity worldwide. A suntan is associated with health, beauty, status and wealth. Many leisuretime activities, such as swimming, tennis, golf, and fishing, are done in the sun. Furthermore, many people are forced to be in the sun for long periods of time due to their occupation.
However, the damaging effects of ‘ualight on skin are well documented. Contrary to what most pe.,ople believe, it is not necessary that one sunbathe to suffer the ill-effects of excessive UV exposure. In fact, a lot of damage can be done just by routine day-to-day activities in tt- sunlight. Some scientists estimate that over 70 percent of the damage the sun inflicts on the average person’s skin over a lifetime is the result of simplV being outdoors or even sitting by a window.
The major short term hazard of prolonged exposure to sunlight is erythema sunburn). The 290 to 320 nanometer wavelength ultraviolet radiation range, designated as the «UVB» wavelength range, tends to be the primary cause of erythema.
The 320 to 400 nanometer wavelength ultraviolet radiation range, designated as the «UVA» wavelength range, also produces ery- I 30 thema.
In addition to the short term hazard of erythema, there are also long term hazards associated with UV radiation exposure.
One of these long term hazards is malignant changes in the skin surface. Numerous epidemiologic studies demonstrate a strong relationship between sunlight exposure and human skin cancer.
S Y» Another long term hazard of ultraviolet radiation is premature lS, aging of the skin. This condition is characterized by wrinkling ro
I
-2and yellowing of the skin, along with other physical changes such as cracking, telangiectasis (spider vessels), solar keratoses (growths), ecchymoses (subcutaneous hemorrhagic lesions), and loss of elasticity (sagging). The adverse effects associated with exposure to UVA and UVB wavelength radiation are more fully 1 discussed in DeSimone, «Sunscreen and Suntan Products», Handbook of Nonprescription Drugs, 7th Ed, Chapter 26, pp. 499-511 I (American Pharmacert’ical Association, Washington, 1982); I Grove and Forbes, «A Method for Evaluating the Photoprotection Action of Sunscreen Agents Against UV-A Radiation», Internationj al Journal of Cosmetic Science, 4, pp. 15-24 (1982); and U.S.
Patent 4,387,089, DePolo, issued June 7, 1983; the disclosures of all of which are incorporated herein by reference. -ance, although the immediate effects of ultraviolet radiation may be cosmetically and socially gratifying, the long-term hazards are cumulative and potentially serious.
The fact that these effects are taken seriously by the general public is suggested by considering the sun protection products’ market. This market has grown considerably in recent years and many new products are introduced each year. What used to be looked upon as a seasonal business is no longer. Sun protection compounds are now included in a diversity of personal care products, particularly cosmetic-type products which are worn on I a daily basis.
i 25 Obviously the most effective way to avoid excessive UV exposure is to simply refrain from being out in the sun. This is n rot only an impractical solution but an impossible one for those Swho work out-of-doors. Furthermore, some effects of exposure to sunlight are beneficial. Vitamin D is synthesized In skin exposed 30 to UV radiation. A deficiency of this vitamin in the body can 1- cause rickets or osteomalacia. Also, recent research suggests that sunlight can alter physical processes in ways that could L enhance one’s feeling of well-being.
S, Sunscreening agents exist naturally in the skin. These include melanin, carotenoids, urocanic acid, proteins and lipids.
These natural sunscreens do not afford complete protection -3however, and for persons with very light skin they affor’d little protection at all.
Over the years, many means have been conceived of to mitigate the effects of UV-exposure. In Middle Eastern couJntries people shield their skin with long robes, kaffiyehs and veils.
This is not an acceptable solution for most people however.
Sunblock agents are commercially available to protect the skin from UV radiation. These agents scatter or reflect ultravioi| let radiation. Examples include titanium dioxide and zinc oxide.
ij 10 However, compositions containing these agents are opaque, generally unattractive in color, and are viewed as unacceptable for jj usage on more than just the nose or tops of the ears. Furtherj more, these agents are very susceptible to rub-off or wear-off resulting in little or no protection.
Another type of agent available is one which provides a «tan» withoJt exposure to the sun. Such agents generally consist of a skin dye and in no way protect against harmful UV-irradiation. These agents are applied to the skin wherever the appearance of a tan is desired. One example is dihydroxyacetone, which provides color through a reaction with specific amino acids in the stratum corneum. A drawback of this type of ;i product is that it results in uneven coloration and a somewhat S, unnatural reddish-brown hue.
Related to these products are artificial tanning compounds which are taken orally. One example is canthaxanthin. These compounds apparently work by coloring the fat cells under the epidermal layer. Such products also result in uneven tanning and require continual maintenance doses. Again, these products provide no protection against harmful irradiation.
The most common agents for sun protection are sunscreens.
These agents exert their effects through chemical means, i.e., they absorb ultraviolet radiation so that it cannot penetrate the skin. Sunscreens present the user with several problems. For example, they must be on the surface of the skin at the time of exposure to be effective. Sunscreens are preventative so onr, must anticipate being in the sun. To be most effective, -4sunscreens must be on the skin as a continuous uniform film.
i Delivering such a film to the surface of the skin is very difficult; maintaining the film over time is almost impossible. Sunscreens must remain on the surface of the skin during exposure. Howi 5 ever, sunscreens are easily rubbed off or washed off by sweating or swimming and can also be lost by penetration into the skin.
Sunscreening agents often cause irritation to the skin and eyes, primarily burning or stinging, respectively. Another problem with sunscreens is that the greater their efficacy, the more the tanning response is decreased.
Methods have been suggested for improving the look of skin I after the UV-induced damage has occurred. Topical application of collagen as a moisturizing agent is one such method. Others I involve injections of collagen or dimethylpolysiloxane. Yet another procedure entails the application of a chemical preparation to the skin to effect a «chemical peel».
Alternatively, methods have been suggested for repairing skin after UV-induced damage has occurred. One such method Involves application of retinoic acid to the skin as disclosed in 20 U.S. Patent 4,603,146, Kligman, issued July 29, 1986. None of these procedures have been proven to be fully effective and most involve extensive and costly treatment. Clearly, it would be far better to prevent the damage induced by UV-irradiation before it occurs. A photo-protectir.g agent which protects against both short-term and long-term UV-damage to the skin while, at the same time, allows for tanning of the skin In a safe, convenient manner would be most ideal.
Tocopherol (Vitamin E) has been disclosed for use as a photoprotector In topical compositions. See, U.S. Patent i 30 4,144,325, Voyt, issued March 13, 1974. Tocopherol works to protect the skin from deleterious effects of UV-irradiation without Interfering with the tanning response. However, cosmetic industry experience suggests that tocopherol may have stability problems, specifically oxidation problems. One frequently used approach to address these problems involves the formulation of compositions Including esters of tocopherol, these esters generally being more stable than tocopherol itself. U.S. Patent 4,248,861, Schutt, issued February 3, 1981, disclo? 0 the use of tocopherol acetate, tocopherol succinate, tocopherol propionate, and toco- I pherol oleate for preventing deleterious effects to skin of solar radiation. U.S. Pater 4,000,276, Hasunuma et al., issued December 28, 1976, disclL es a cosmetic composition comprising toi copherol orotate. Tocopherol benzoate, p-aminobenzoate, and p-nitro-benzoate have been disclosed for use in sunscreen compot sitions in European Patent Application 166,221, Tuominen, published January 2, 1986. The linoirate, nicotinate, and 2-ethylhexanoate esters of tocopherol have been disclosed for use in cosmetic compositions in Japanese Laid-Open Application i 61-143,331, published December 14, 1984. Incrased formulational i stability, as provided by most tocopherol esters, unfortunately j 15 comes at the cost of decreased photoprotection efficacy. Clearly, a photo-protecting agent whicl works as well as tocopherol but which is not subject to stability problems would be most desirable.
The topical use of anti-inflammatory agents to alleviate 20 erythema is known. Compositions conteiining steroidal antii inflammatories, non-steroidal anti-inflammatories, as well as «natural» anti-inflammatories, such as- an extract of the plant Aloe *vera, have been disclosed for such use. See U.S. Patent 4,185,100, Rovee, issued January 22, 1980 (hydrocortisone, dexamethasone, naproxen, ketcprofen, ibuprofen); U.S. Patent 4,338,293, Holick, issued July 6, 1982, (steroidal anti-inflammatories); Law, et al., Br. J. Pharmac. 59(4), 591-597 (1977) (Ibuprofen); Kaidbey, J. Invest. Dermatology, 66, 153-156 (1976) (indomnthacin); and Gruber, et al., Clinical Pharm. and Therapeut., 13(1), 109-113 (1971) (aspirin, fenoprofen). Short-term application of anti-inflammatory agents prior to UV exposure to prevent erythema, as well as application after UV exposure to lessen UV-lnduced damage to skin, has been taught.
It is an object of the present invention to provide a topical composition in a stable form, the use of which will prevent both l I S-6- Sacute (erythema) and chronic (photoaging) effects of exposure to i the sun.
i It is also an object of the present invention to provide a Stopical composition, a cleansing composition, and a method for preventing these deleterious effects of the sun without interfering with the tanning response.
It is further an object of the present invention to provide a photoprotection composition which penetrates into the skin and which is less susceptible to rub-off, wear-off or wash-off.
It is a still further object of the present invention to i provide a photoprotection composition which can be applied to the skin in advance of UV exposure without significant loss of i efficacy.
SUMMARV OF THE INVENTION The present invention relates to a composition useful for topical application comprising a photoprotectively effective amount of tocopherol sorbate and a safe and effective amount of a topical carrier.
The present invention also relates to a composition useful for topical application comprising a photoprotectlvely effective amount of tocopherol sorbate, a photoprotectively effective amount of a sunscreening agent, and a safe and effective amount of a topical’ carrier.
The present invention further relates to a method of inhibit- Ing the deleterious effects of ultraviolet light exposure to skin i comprising applying a safe and photoprotectively effective amount S of tocopherol sorbate to the skin in conjunction with exposing the skin to ultraviolet light.
I The present i;vention further relates to a method of inhibit- Ing the deleterious effects of ultraviolet light exposure to skin ,comprising applying a safe and photoprotectively effective amount of tocopherol sorbate and a safe and photoprotectively effective amount of a sunscreening agent to the skin in conjunction with exposing the skin to ultraviolet light.
Li 7 DETAILED DESCRIPTION OF THE INVENTION Active Agent The present invention relates to the topical use of compositions containing tocopherol sorbate to prevent the deleterious effects of UV exposure. Tocopherol sorbate is the tocopherol (more commonly known as Vitamin E) ester of sorbic acid.
Tocopherol sorbate can be synthesized by standard esterification methods known in the art. Any of the tocopherols are suitable for esterification, including the monomethyl, dimethyl or trimethyl derivatives of tocol. More specifically any of alpha tocopherol (5,7,8-trimethyl tocol), beta tocopherol (5,8-dimethyl tocol), gamma tocopherol (7,8-dimethyl tocol), delta tocopherol (8-methyl tocol), epsilon tocopherol (5-methyl tocol), zeta tocopherol (5,7-dimethyl tocol), and eta tocopherol (7-methyl tocol) may be used to make tocopherol sorbate. Some of these isomers i may be more efficacious for photoprotection than others. The beta, gamma and delta tocopherols exhibit particularly strong anti-oxidant properties and thus may be preferred for making the photoprotectors of the present inven’on. Mixtures of these 2 <20 isomers may also be used to make the tocopherol sorbate useful for the present invention. Tocopherol sorbate may be made, for example, by first combining one mole of dl-alpha-tocopherol with about 4.3 moles of polyphosphate ester. One mole of sorbic acid is then added to 25 the reaction mixture and the solution is stirred for about 16 hours. The sample is washed with an equal volume of deionized water and an equal volume of diethylether is added. The layers are separated and the organic layer is washed with 8.7 liters of sodium bicarbonate (1 kg/12 I of water). Four liters of anhydrous ether are added to achieve separation of the phases. The organic layer is dried over 1 kg of sodium sulfate, anhydrous. The organic fraction is decanted from sodium sulfate and dried by rotoevaporation at about 50°C and about 30 mm Hg to give about 574 grams. The sample is washed with one liter of hexanis to remove any solid or residual chloroform. The sample Is dried to yield about 500 g of a yellow/brown viscous oil of greater than 99% purity. S- 8 -8- A safe and photoprotectively effective amount of tocopherol sorbate is used in the compositions of the present invention. By I; "safe and photoprotectively effective" amount is meant an amount !i sufficient to provide photoprotection when the composition is properly applied, but not so much as to cause any side effects or adverse skin reactions; generally from about 1% to about preferably from about 2% to about 10%, of the composition. It is important to note that tocopherol sorbate is a nonsunscreen photoprotecting agent. A sunscreen works on thsurface of the skin to absorb UV radiation so that the harmfu: rays never enter the skin. Tocopherol sorbate works in the skin, perhaps by its radical scavenging and photochemical re- I action quenching capabilities which prevent damaging reactions in the skin. Because tocopherol sorbate penetrates tne skin to work, rub-off, wear-off or wash-off of the active, which lessen efficacy for sunscreens considerably, are essentially irrelevant with the present invention. Furthermore, though critical with a sunscreen, it is not necessary to keep an even coating of the active of the present invention on the skin for the entire expo- 2 sure period. Tocopherol sorbate can be applied to the skin up to i four hours or longer prior to UV exposure. Tocopherol sorbate protects against both acute effects of UV exposure, suno burn, and chronic effects of UV exposure, premature aging of the skin. As a radical scavenger the topical use of tocopherol sorbate may also be beneficial to people with extreme sensitivity to S 'sunlight. Such use may enable individuals with these skin disorders to tan. Carriers *j 30 In addition to the active agent, tocopherol sorbate, the compositions of the present invention contain a safe and effective amount of an acceptable carrier. The term "acceptable topical carrier" encompasses both pharmaceutically-acceptable carriers and cosmetically-acceptable carriers, and It encompasses substantially non-irritating compatible components (either taken alone or In mixtures) which are suitable for delivering the active i- -9component to the skin. The term "compatible", as used herein, means that the components of the carrier must be capable of being commingled with tc-opherol sorbate, and with each other, in a manner such that there is no interaction which would sub- 5 stantially reduce the efficacy of the composition during use for protecting the skin from the effects of UV radiation. These carriers must, of course, be of sufficiently high purity and i sufficiently low toxicity to render them suitable for chronic topical administration to the skin of humans or lower animals. The term "safe and effective amount" of carrier means an amount sufficient to deliver the tocopherol sorbate to the skin but not so much as to cause any side effects or skin reactions, generally from about to about 99%, preferably from ibout 90% to about 98%, of the composition. Variations in formulation of these carriers will result in a wide variety of products which fall within the scope of the present invention. These product types can be divided into two classes: pharmaceutical/cosmetic compositions and cleaning compositions. Pharmaceutical/Cosmetic Compositions The pharmaceutical/cosmetic compositions of the present invention may be made into a wide variety of product types. These include, for example, lotions, creams, beach oils, gels, sticks, sprays, ointments, pastes, mousses and cosmetics. These product types may comprise either of two basic types of carrier systems, solutions and emulsions. The pharmaceutical/cosmetic compositions of the present invention formulated as solutions typitally include a pharmaceuti- I cally- or cosmetically-acceptable organic solvent. The terms jj 30 "pharmaceutically-acceptable organic solvent" and "cosmetcalr ly-acceptable organic solvent" refer to an organic solvent which, In addition to being capable of having dispersed or dissolved therein the tocopherol sorbate, also possesses acceptable safety irritation and sensitization characteristics), as well as good aesthetic properties does not feel greasy or tacky). The most typical example of such a solvent is isopropanol. Examples i. o 10 of other suitable organic solvents include: propylene glycol, polyethylene glycol (200-600), polypropylene glycol (425-2025), If glycerol, 1,2,4-butanetriol, sorbitol esters, 1,2,6-hexanetriol, H ethanol, butanediol, water and mixtures thareof. These solutions contain from about 1% to about 20%, preferably from about 2% to about 10%, of tocopherol sorbate, and from about 80% to about 99%, preferably from about 90% to about 98%, of an acceptable organic solvent. If the pharmaceutical/cosmetic compositions of the present invention are formulated as an aerosol and applied to the skin as a spray-on, a propellant is added to a solution composition. Examples of propellants useful herein include the chiorinated, fluorinated and chloro-fluorinated lower molecular weight hydrocarbons. Other propellants useful in the present invention include lower molecular weight hydrocarbon mixtures the mixture o7 butane, isobutane and propane known commercially as S Propellant A46, made by Phillips Chemical Co., a subsidiary of Phillips Petroleum Company), ethers and halohydrocarbons such as dimethyl ether or dichlorodifluoromethane alone or mixtures thereof with dichlorotetrafluoroethane. Mixtures of hydrocarbon and halohydrocarbon propellants and nitrous oxide may also be used. Nitrogen and carbon dioxide can also be used as propellant gases. They are used at a level sufficient to expel the contents of the container. A more complete disclosure of propellants useful herein can be found in Sagarin, Cosmetics Science and Technology, 2nd Edition, Vol. 2, pp. 443-465 (1972), Incorporated herein by reference. Alternatively, emollients may comprise the carrier system of the present Invention formulated as a solution. An example of a composition formulated in this way would be a beach oil product. Such compositions contain from about 1% to about 20% of tocopherol sorbate and from about 2% to about 50% of a pharmaceutlcally/cosmetically-acceptable emollient. As used herein, "emollients" refer to materials used for the prevention or relief of dryness, as well as for the protection of the skin. A wide variety of suitable emollients are known and 11 may be used herein. Sagarin, Cosmetics, e and Techno, 2nd Edition, Vol. 1, pp. 32-43 (1972), incorporated herein by reference, contains numerous examples of suitable materials. Examples of classes of useful emollients include the following: 1. Hydrocarbon oils and waxes. Examples include mineral oil, petrokatum, paraffin, ceresin, ozokerite, microcrystalline wax, polyethylene, and perhydrosqualene. 2. Silicone oils, such as dimethyl polysiloxanes, methylphenyl polysiloxanes, water-soluble and alcohol-soluble silicone glycol copolymers. 3. Triglyceride esters, for example vegetable and animal fats and oils. Examples include castor oli, safflower oil, cottonseed oil, corn oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil, sesame oil, and soybean oil. 4. Acetoglyceride esters, such &s acetylated monoglycerides. i. Ethoxylated glycerides, such as ethoxylated glyceryl monostearate. 6. Alkyl esters of fatty acids having 10 to 20 carbon atoms. Methyl, isopropyl, and butyl esters of fatty acids are particularly useful herein. Examples of other useful alkyl esters include hexyi laurate, isohexyl laurate, isohexyl palmitato., Is,-, propyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stenate. decyl stearate, Isopropyl isostearate, dilsopropyl adlpate, dilsohexyl adipate, dihexyldecyl adipate, "lisopropyl sebacate, lauryl lactate, myristyl lactate, and cetyl lactate. 7. Alkenyl esters of fatty acids having 10 to 20 carbon atoms. Examples Include oleyl myristate, oleyl stearate, and oleyl oleate. 8. Fatty acids having 10 to 20 carbon atoms. Suitable examples Include pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, riclnoleic, arachidic, behenic, and erucic acids. 9. Fatty alcohols having 10 to 20 carbon atoms. Lauryl, myristyl, cetyl, hexadecyl, stearyl, Isostearyl, hydroxystearyl, D 2~iC*I I i U g ii Ib 12 oleyl, ricinoleyl, behenyl, and erucyl alcohols, as well as 2-octyl dodecanol, are examples of satisfactory fatty alcohols. 10. Fatty alcohot ethers. Ethoxylated fatty alcohols of to 20 carbon atoms include the lauryl, cetyl, stearyl, isostearyl, oelyl, and cholesterol alcohols having attached thereto from 1 to ethylene oxide groups or 1 to 50 propylene oxide groups. 11, Ether-esters such as fatty acid esters of ethoxylated fatty alcohols. 12. Lanolin and derivatives. Lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, ethoxylated lanolin, ethoxylated lanolin alcohols, ethoxylated cholesterol, propoxylated lanolin alcohols, acetylated lanolin, acetylated lanolin alcohols, lanolin alcohols linoleate, lanolin alcohols ricinoleate, acetate of lanolin alcohols ricinoleate, acetate of ethoxylated alcohols-esters, hydrogenolysis of lanolin, ethoxylated hydrogenated lanolin, ethoxylated sorbitol lanolin, and liquid and semisolid lanolin absorption bases are illustrative of emollients deri.ved from linalln. 13. Po ptydric alcohols and polyether derivatives. Propylene glycol, dipropylene glycol, polyprcp*lene glycols 2000 and 4000, polyoxyethylene polyoxypropylene glycols, polyoxypropylene polyoxyethylene glycols, glycerol, sorbitol, ethoxylated sorbitol, hydroxypropyl sorbitol, polyethylene glycols 200-6000, methoxy polyethylene glycols 350, 550, 750, 2000 and 5000, poly[ethylei-, oxide] homopolymers (100,000-5,000,000), polyalkylene glycols and derivatIves, hexylene glycol (2-oiethyl-2,4-pentanedlol), 1,3utylene glycol, 1,2,6-hexanetriol, ethohexadiol USP (2-ethyl- 1.3-hexanediol), C 15 -C18 vicinal glycol, and polyoxypropylene derivatives of trimethylolpropane are examples of this class of 30 materials. 14. Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylited propylene glycol monostearate, glyceryl -13mono- and di-fatty acid esters, polyglycero, poly-fatty acid esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric I alcohol esters for use herein. Wax esters such as beeswax, spermaceti, myristyl i myristate, stearyl stearate. i 16. Beeswax derivatives, e.g. polyoxyethylene sorbitol beeswax. These are reaction products of beeswax with ethoxylated sorbitol of varying ethylene oxide content, forming a mixture of ether-esters. 17. Vegetable waxes including carnauba and candelilla waxes. 18. Phospholipids, such as lecithin and derivatives. 19. Sterols. Cholesterol and cholesterol fatty acid este's Iare examples thereof. 20. Amides such as fatty acid amides, ethoxylated fatty acid amides, solid fatty acid alkanolamides. 20 Particularly useful emollients which provide skin conditioning i are glycerol, hexanetriol, butanetriol, lactic acid and its salts, urea, pyrrolidone carboxylic acid and its salts, amino acids, i guanidine, diglycerol and triglycerol. Preferred skin conditioning agents are the propoxylated glycerol derivatives disclosed In U.S. Patent Application Serial No. 023,059, Orr et al., filed March 6, 1987. These agents preferably have a frr,ula selected from: OH OH CH I 1 3 SCH -CH-CH2 (OCH 2 -CH) OH, H 2 2 n OH OH CH CH 2 H-CH2 (OCH-CH 2 OH, OH OH CH CH 1 3 1 3 CH 2 -CH-CH-O-CH H-O-CH-CH OH and OH OH CH 3 CH 3 CH 2 -CH--C -O-C,-CH 2 -0-C 2-H-OH 2 2 2 14wherein n 1 or 2, and mixtures thereof. Preferably any of the compositions of the present invention compric. from about 1% to about 10% by weight of this propoxylated glycerol derivative. A lotion can be made from a solution carrier system. Lotions typicaly comprise from about 1% to about 20%, preferably from about 2% to about 10%, tocopherol sorbate; from about 1% to about preferably from about 5% to about 10%, of an emollient; and from about 50% to about 90%, preferably from about 60% to about water. Another type of product that may be formulated from a solution carrier system is a cream. A cream of the present invention would comprise from about 1% to about 20%, preferably from about 2% to about 10%, tocopherol sorbate; from aboul 5% to about 50%, preferably from about 10% to about 20%, of an emollient, and from about 45% to about 85%, preferably from about 50% to about 75%, water. Yet another type of product that may be formulated from a solution carrier system is an ointment. An ointment may comprise a simple base of animal or vegetable oils or semi-solid hydrocarbons (oleaginous). Ointments may also comprise absorption ointment bases which absorb water to form emulsionr Examples of such ointment bases include anhydrous lanolin and hydrophilic petrolatum. Emulsion ointment bases may be oll-in-water or water-in-oil emulsions. Ointment carriers may also be water soluble. Examples of such ointment carriers include glycol ethers, propylene glycols, polyoxyl stearates, and polysorbates. An ointment may a;so comprise from about 2% to about 10% of an emollient plus from about 0.1% to about 2% of a thickening agent. Examples of suitable thickening agents include: cellulose derivatives (e methyl cellulose and hydroxy propyl- ,I 30 methyl cellulose), synthetic high molecular weight pou'cywr- carboxyvinyl polymer and polyvinyl alcohol), plant hydrocolloids karaya gum and tragacanth gum), clay thickeners colloidal mragnesium aluminum silicate and bentonite), and carboxyvinyl polymers (Carbopols R sold by B. F. Goodrich Company, such polymers are described in detail in U.S. Patent 2,798,053, Brown, issued July 2, 1957, incorporated herein by in-t. illl ~ll r I'' 15 reference). A more complete disclosure of thickening agents useful herein can be found in Sagarin, Cosmetics, Science and Technology, 2nd Edition Vol. 1, pp. 72-73 (1972), incorporated herein by reference. If the carrier system is formulated as an emulsion, from about 1% to about 10%, preferably from about 2% to about of the carrier system comprises an emulsifitr. Emulsifiers may be nonionic, anionic or cationic. Suitable amulsifiers are disclosed in, for example, U.S. Patent 3,755,560, issued August 28, 1973, Dickert et al.; U.S. Patent 4,421,769, issued December 20, 1983, Dixon et al.; and McCutcheon's Detergents and Emulsifiers, North American Edition, pages 317-3:4 (1986); the disclosures of which are incorporated herein by reference. Preferred emulsifiers are anionic or nonionic, although the other types may also be used. Examples of useful nonionic emulsifiers include fatty alcohols having 10 to 20 carbon atoms, fatty alcohols having 10 to carbon atoms condensed with 2 to 20 moles of ethylene oxide or propylene oxide, alkyl phenols with 6 to 12 carbon atoms in the alkyl chain condensed with 2 to 20 moles of ethylene oxide, monoand di-fatty acid esters of ethylene glycol wherein the fatty acid moiety contains from 10 to 20 carbon atoms, fatty acid monoglycerides wherein the fatty acid moiety contains from 10 to carbon atoms, diethylene glycol, polyethylene glycols of molecular weight 200 to 6000, propylene glycol of molecular weight 200 to 3000, sorbitol, sorbitan, polyoxyethylene sorbitol, polyoxyethylene sorbitan and hydrophilic wax esters. Examples of such emulsifiers include polyoxyethylene stearatc, myristyl ethoxy (3) myristate, polyoxyethylene (100) monostearate, lauric diethdnolamide, stearic monoethanolamide, hydrogenated vegetable glycerides, sodium stearoyl-2-lactylate and calcium stearoyl- 2-lactylate. Suitable anionic emulsifiers include the fatty acid soaps, sodium, potassium, and triethanolamine soaps, wherein the fatty acid moiety contains from 10 to 20 carbon atoms. Other suitable anionic emulsifiers include the alkali metal, ammonium or substituted ammonium alkyl sulfates, alkyl arylsulfonates, and enhance one's teeling or well-Deing. Sunscreening agents exist naturally in the skin. These include melanin, carotenoids, urocanic acid, proteins and lipids. These natural sunscreens do not afford complete protection J 16 alkyl ethoxy ether sulfonates having 10 to 30 carbon atoms in the alkyl moiety. The alkyl ethoxy ether sulfonates contain from 1 to ethylene oxide units. Cationic emulsifiers useful in the present invention include quaternary ammonium, morphollnium and pyridinium compounds. Examples of such emulsifiers include dialkyl (C 1 2 -C1 quaternary ammonium salts, cetyl trimethyl ammonium salts; alkyl dimethyl benzyl ammonium salts, and cetyl pyridinium salts. Single emulsion skin care preparations, such as lotions and creams, of the oil-in-water type and water-in-oil type are wellknown in the cosmetic art and are useful in the present invention. Multiphase emulsion compositions, such as the waterin-oil-in-water type, as disclosed in U.S. Patent No. 4,254,105, Fakuda et al., issued March 3, 1981, herein incorporated by reference, are also useful in the present invention. In general, such single or multiphase emulsions contain w9ter, emollients and emulsifiers as essential ingredients. Triple emulsion carrier systems comprising an oil-in-waterin-silicone fluid emulsion composition as disclosed in U.S. Patent Application Serial No. 022,876, Figueroa et al., filed March 6, 1987, herein incorporated by reference, are also useful in the present Invention. More particularly, such triple emulsion carrier systems comprise a) from about 15% to about 90% by weight (of the vehicle) of a silicone fluid continuous phase consisting essentially of at least one liquid organopolysiloxane b) from about 30% to about 80% by weight (of the vehicle) of an aqueous discontinuous phase comprising an oil-in-water emulsion of a cosmetically-acceptable oily liquid non-particulate phase dispersed 1 in an aqueous phase, and c) from about 0.5% to about 5% by weight (of the vehicle) of an effective dispersing amount of dimethicone copolyol for dispersing in Preferably said liquid organopolysiloxane consists of one or more volatile organopolysiloxanes selected from the group consist- Ing of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, cyclomethicone, and hexamethyldislloxane in a mixture with one or more non-volatile example, they must be on the surface of the skin at the time of exposure to be effective. Sunscreens are preventative so one must anticipate being in the sun. To be most effective, i -17i 17 organopolysiloxanes selected from the group consisting of: dimethicone copolyol, dimethylpolysiloxane, diethyipolysiloxane, mixed C 1 -C 3 alkyl polysiloxane, phenyl dimethicone and a high molecular weight dimethicone having an average molecular wc'grit of from about 200,000 to about 1,000,000, in a respective weight ratio of from about 5:1 to about 25:1, and said oily phase comprises heavy mineral oil, cholesterol and cetyl palmitate in a respective weight ratio of about 10:5:1. This triple emulsion carrier system can be combined with J 10 from about 1% to about 20%, preferably from about 2% to about tocopherol sorbate to yield the pharmaceutical/cosmetic composition of the present invention. Another emulsion carrier system useful in the pharmaceutical/cosmetic compositions of the present Invention is a microj 15 emulsion carrier syster. Such a system comprises from about 9% to about 15% squalane; from about 25% to about 40?i silicone oil; j from about 8% to about 20% of a fatty alcohol; from about 15% to i about 30% of polyoxyethylene sorbitan mono-fatty acid (commer- S. cially available under the trade name Tweens) or other nonionics; and from about 7% to about 20% water. This carrier system is combined with from about 2% to about 10% tocopherol sorbate. I Lotions and creams can be formulated as emulsions as well as I solutions. Typical!y such lotions comprise from about 1% to abqut preferably from about 2% to about 10%, tocopherol sorbate; 'rom about 1% to about 20%, preferably from about 5% to about of an emollient; from about 25% to about 75%, preferably from about 45% to about 95%, water; and from about 1% to about preferably from about 2% to about of an emulsifier. Such creams would typically comprise from about 1% to about preferably from about 2% to ab~ut 10%, tocopherol sorbate; from about 1% to about 20%, preferably from about 5% to about 10%, of an emollient; from about 20% to about 80%, preferably from about to about 70%, water; and from about 1% to about 10%, preferably from about 2% to about of an emulsifier. If the pharmaceutical/cosmetic compositions of the present invention are formulated as a gel or a cosmetic stick, a suitable u y prierimnce suggests tnat tocopherol may nave staDility proolems, specifically oxidation problems. One frequently used approach to address these problems involves the formulation of compositions including esters of tocopherol, these esters generally i S- 18 amount of a thickening agent as disclosed supra, is added to a cream or lotion formulation. The pharmaceutical/cosmetic compositions of the present invention may also be formulated as makeup products, such as foundations or lipsticks. Foundations are solution or lotionbased with appropriate amounts of thickeners, pigments and fragrance. Lipsticks are composed essentially of an oil-wax base stiff enough to form a stick, with pigmentation dispersed therein. The topical pharmaceutical/cosmetic compositions of the present invention may contain, in addition to the aforementioned j components, a wide variety of additional oil-soluble materials, ft I and/or water-soluble materials conventionally used in topical compositions, at their art-established levels. Among the optional oil-soluble materials are nonvolatile silicone fluids, such as polydimethyl siloxanes with viscosities ranging from about 10 to about 100,000 centistokes at 250C. These siloxanes are useful to enhance skin feel and are available from Dow Corning Corporation as the Dow Corning 200 series. These optional oil-soluble materials may comprise up to about of the total composition, preferably up to about Various water-soluble materials may also be present in the compositions of this invention. These include humectants, such as glycerol, sorbitol, propylene glycol, alkoxylated glucose and hexanetriol, ethyl cellulose, polyvinyl alcohol, carboxymethyl cellulose, vegetable gums and clays such as VeegumR (magnesium *aluminum silicate, R. T. Vanderbilt, Inc.); proteins and polypeptides; preservatives such as the methyl, ethyl, propyl and I butyl esters of hydroxybenzoic acid (Parabens Mallinckrodt I\ Chemical Corporation), EDTA, methylisothiazolinone and imidazolidinyl ureas (Germall 115 Sutton Laboratories); and an alkaline agent such as sodium hydroxide or potassium hydroxide to neutralize, if desired, part of the fatty acids or thickener which 9It may be present. In addition, the topical compositions herein can contain conventional cosmetic adjuvants, such as dyes, opacifiers titanium dioxide), pigments and perfumes. ri~ I r-nir i ""xie~ 19 The pharmaceutical/cosmetic compositions of the present invention may also include a safe and effective amount of a penetration enhancing agent. By "safe and effective amount" is meant an amount sufficient to enhance penetration of tocopherol sorbate Into the skin but not so much as to cause any side effects or skin reactions, generally from about 1% to about 5% of the composition. Examples of useful penetration enhancers, among others, are disclosed in U.S. Patents 4,537,776, Cooper, issued August 27, 1985; 4,552,872, Cooper et al., issued November 12, 1985; 4,557,934, Cooper, issued December 10, 1985; 4,130,667, Smith, issued December 19, 1978; 3,989,816, Rhaadhyaksha, issued November 2, 1976; 4,017,641, DiGiulio, issued April 12, 1977; and European Patent Application 0043738, Cooper et al., published January 13, 1982. U.S. Patent 4,537,776 teaches a penetrationenhancing vehicle consisting essentially of a) N-(2-hydroxyethyl) pyrrolidone and b) a cell envelope disordering compound selected from methyl laurate, oleic acid, oleyl alcohol, monoolein, myristyl alcohol, and mixtures thereof, wherein component and are present In a ratio of of about 1:5 to about 500:1 by weight. U.S. Patent 4,557,934 teaches a pharmaceutical composition comprising the penetration enhancing agent 1-dodecylazacycloheptan-2-one, and a penetration enhancing diol or cycloketo compound selected from the group consisting of: 1,2-propanediol, 1,3 ,propanediol, 1,2-butanedlol, pyrrolidone; 1-(2-hydroxyethyl)azacyclopentan-2-one, and mixtures thereof. U.S. Patent 4,130,667 describes a penetration enhancer comprising: at least about 0.1% by weight of a sugar ester selected from sucrose monooctanoate, sucrose monodecanoate, sucrose monolaurate, sucrose monomyristate, sucrose monopalmitate, sucrose monostearate, sucrose monooleate, and sucrose dioleate; and at least about 0.1% by weight of a phosphine oxide compound selected from octyldimethyl phosphine oxide, nonyl dimethyl phosphine oxide, decyl dimethyl phosphine oxide, undecyl dimethyl phosphine oxide, dodecyl dimethyl phosphine oxide, 2-hydroxydecyl dimethyl phosphine oxide, 2-hydroxy undecyl dimethyl phosphine L_ 20 oxide, and 2-hydroxy dodecyl dimethyl phosphine oxide. Sulfoxides may be used in some executions in place of the phosphine oxide. 5 Other conventional skin care product additives may also be included in the compositions of the present invention. For example, collagen, hyaluronic acid, elastin, hydrolysates, primrose oil, jojoba oil, epidermal growth factor, soybean !I saponins, mucopoly.jccharides, and mixtures thereof may be used. Various vitamins may also be included in the compositions of the present invention. For example, Vitamin A and derivatives thereof, Vitamin B2, biotin, pantothenic acid, Vitamin D and mixtures thereof may be used. Cleaning Compositions ij The skin cleaning compositions of the pr.seni: invention i comprise, in addition to tocopherol sorbate, a cosmetically- Sacceptable surfactant. The term "cosmetically-acceptable suri factant" refers to a surfactant which is not only an effective skin cleanser, but also can be used without undue toxicity, irritation, Sallergic response, and the like. Furthermore, the surfactant must be capable of being commingled with tocopherol sorbate in, a i manner such that there is no interaction which would substantially Sreduce the efficacy of the composition for protecting the skin from the effects of UV radiation. The skin cleaning compositions of the present Invention contain from about 1% to about 25%, preferably from about 5% to I about 10%, tocopherol sor 9te, and from about 1% to about preferably from about 50% to about 85%, of a cosmeticallyacceptable surfactant. The physical form of the skin cleansing compositions is not critical. The compositions can be, for example, formulated as toilet bars, liquids, pastes, or mousses. Toilet bars are most preferred since this is the form of cleansing agent most commonly used to wash the skin. The surfactant component of the compositions of the present Invention is selected from anionic, nonionic, zwitterionic, rotoevaporation at about 50 0 C and about 30 mm Hg to give about 574 grams. The sample is washed with one liter of hexanes to remove any solid or residual chloroform. The sample is dried to yield about 500 g of a yellow/brown viscous oil of greater than 99% purity. -a 21 amphoteric and ampholytic surfactants, as well as mixtures of these surfactants. Such surfactants are well-known to those skilled in the detergency art. The most common type of anionic surfactants can be broadly described as the water-soluble salts, particularly the alkali metal salts, of organic sulfuric reaction products having in the molecular structure an alkyl radical containing from about 8 to about 22 carbon atoms and a radical selected from the group consisting of sulfonic acid and sulfuric acid ester radicals. Important examples of these surfactants are the sodium, ammonium or potassium alkyl sulfates, especially those obtained by sulfating the higher alcohols produced by reducing the glycerides of tallow or coconut oil; sodium or potassium alkyl benzene sulfonates in which the alkyl group contains from about 9 to about 15 carbon atoms, especially those of the types described In U.S. Patents 2,220,099 and 2,477,?33, incorporated herein by reference; sodium alk,/l glyceryl ether sulfonates, especially those ethers of the higher alcohols derived from tallow and coconut oil; sodium coconut oil S' fatty acid monoglyceride sulfates and sulfonates; sodium or potassium salts of sulfuric acid esters of the reaction product of one j mole of a higher fatty alcohol tallow or coconut oil alcohols) and about three moles of ethylene oxide; sodium or poi tassium salts of alkyl phenol ethylene oxide ether sulfates with about three moles of ethylene oxide; sodium or potassium salts of i 25 alkyl phenol ethylene oxide; sodium or petassium salts of alkyl j phenol ethylene oxide ether sulfates with about four units of j ethylene oxide per molecule and in which the alkyl radicals contain about 9 carbon atoms; the reaction product of fatty acids esterified with isethionic acid and neutralized with sodium hydroxide where, for example, the fatty acids are derived from coconut oil; sodium or potassium salts of fatty acid amide of a methyl taurine In which the fatty acids, for example, are derived from i, coconut oil; and others known in the art, such as those specif- Ically set forth in U.S. Patents 2,486,921, 2,486,922 and 2,396,278, incorporated herein by reference. An important type of useful anionic surfactants are soaps. Soaps which can be used as the surfactant in the present 11-I ~lir i i i i, 22 compositions include alkali metal sodium or potassium) soaps of fatty acids containing from about 8 to about 24, preferably from about 10 to about 20, carbon atoms. The fatty acids used in making the soaps can be obtained from natural sources such as, for instance, plant or animal-derived glycerides palm oil, coconut oil, babassu oil, soybean oil, castor oil, tallow, whale oil, fish oil, grease, lard, and mixtures thereof). The fatty acids can also be synthetically prepared by i oxidation of petroleum stocks or by the Fischer-Tropsch process). Alkali metal soaps can be made by direct saponification of the fats and oils or by the neutraliFtion of the free fatty acids which are prepared in a separate manufacturing process. Particularly useful are the sodium and potassium salts of the mixtures of fatty acids derived from coconut oil and tallow, sodium and potassium tallow and coconut soaps. The term "tallow" as used herein in connection with fatty 'i acid mixtures refers to acids which typically have an approximate ij carbon chain length distribution of 2.5% C14, 29% C16 23% C 1 8 S2% palmitoleic, 41.5% oleic and 3% linoleic acid (the first three i 20 fatty acids listed are saturated). Other mixtures with similar distributions, such ai the fatty acids derived from various animal j tallows and lard, are also included within the term tallow, The i, tallow can also be hardened hydrogenated) to convert part or all of the unsaturated fatty acid moieties to saturated fatty i 25 acid moieties. The term "coconut oil" as used herein refers to fatty acid j mixtures which typically have an approximate carbon chain length distribution of about 8% Cg, 7% C10, 48% C12, 17% C 9% C1 "1 2% C 1 8 7% oleic, and 2% linoleic acid (the first six fatty acids listed being saturated). Other sources having similar carbon chain length distribution, such as palm kernel oil and babassu oil, are included with the term coconut o! l Nonionic surfactants may be broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound, which may be alip'hatic or alkyl aromatic in nature. The length of the 23 hydrophilic or polyoxyalkylene radical which is condensed with any particular hydrophobic group can be readily adjusted to yield a water-soluble compound having the desired degree of balance between hydrophilic and hydrophobic elements. For example, a well-known class of nonionic surfactants is commercially available under the trade name "Pluronic" marketed by the BASF Wyandotte Corporation. These compounds are formed by condensing ethylene oxide with a hydrophobic base formed by the condensation of propylene oxide with propylene glycol. The hydrophobic portion of the molecule which, of course, exhibits water-insolubility has a molecular weight of from j about 1500 to about 1800, The addition of polyoxyethylene radicals to this hydrophobic portion tends to increase the watersolubility of the molecule as a whole and the liquid character of the products is retained up to the point where polyoxyethylene content is about 50% of the total weight of the condensation product. Other suitable nonionic surfactants Include, for example: The polyethylene oxide condensates of alkyl phenols, i 20 the condensation products of alkyl phenols having an alkyl group containing from about 6 to about 12 carbon atoms in either a straight chain or branched chain configuration, with ethylene oxide, the said ethylene oxide being present in amounts equal to from about 5 to about 25 moles of ethylene oxide per mole of alkyl phenol. The alkyl substltuert in such compounds may be derived from polymerized propylene, dilsobutylene, octane, and nonane, for example. Examples of compounds of this type Include nonyl Sphenol condensed with about 9.5 moles of ethylene oxide per mole of phenol; dodecyl phenol condensed with about 12 moles of ethylene oxide per mole of phenol; dinonyl phenol condensed with about 15 moles of ethylene oxide per mole of phenol; and dlisooctyl phenol condensed with about 15 moles of ethylene oxide per mole of phenol. Commercially available nonionic surfactants of this type Include igepal CO-630, marketed by the GAF Corporatlon; and Triton X-45, X-114, X-100, and X-102, all marketed by the Rohm Haas Company. I- 24 (ii) Those derived from the condensation of ethylene oxide with the product resulting from the reaction of propylene oxide i and ethylene diamine-products which may be varied in composition j depending upon the balance between the hydrophobic and hydrophilic elements which is desired. Examples are compounds containing from about 40% to about 80% polyoxyethylene by weight and having a molecular weight of from about 5,000 to about 11,000 resulting from the reaction of ethylene oxide groups with a hydrophobic base constituted of the reaction product of ethylene di'mine and excess propylene oxide, said base having a molecular weight of the order of 2500 to 3000. Examples of this type of nonlonic surfactant include certain of the commercially available Tetronic compounds, marketed by Wyandotte Chemical Corporation, (1ii) The condensation product of aliphatic alcohols having from 8 to 18 carbon atoms, In either straight or branched chain configuration, with ethylene oxide, a coconut alcohol ethylene oxide condensate having from 10 to 30 moles of ethylene d oxide per mole of coconut alcohol. Examples of commerclaiiy available nonionic surfactants of this type Include Tergitol 15-S-9 (the condensation product of C '-C 1 5 secondary alcohol with 9 moles ethylene oxide), marketed by Union Carbide Corporation; Neodol 45-9 (the condensation product of C4-C15 linear alcohol with 9 moles of ethylene oxide), Neodol 45-7 (the condensation product of C 1 4 -C 15 linear alcohol with 7 moles of ethylene oxide), Neodol 45-4 (the condensation product of C 4 -C 15 linear alcohol with 4 moles of ethylene oxide), marketed by Shell Chemical Company, and Kyro EOB (the condensation product of C 13 -C 1 linear alcohol with 9 moles of ethylene oxide), marketed by The Procter Gamble Company. (Iv) Trialkyl amine oxides and trialkyl phosphine oxides wherein one alkyl group ranges from 10 to 18 carbon atoms and two alkyl groups range from 1 to 3 carbon atoms; the alkyl groups can contain hydroxy substituents, Specific examples Include dodecyl (dl-2-hydroxyethyl)amine oxide and tetradecyl dimethyl phosphlne oxide. -i i' i. 1;;-11 II~-LU~X- 25 Zwitterionic surfactants comprise the betaine and betaine-like compounds wherein the molecule contains both basic and acidic groups which form an inner salt giving the molecule both cationic and anionic hydrophilic groups over a broad range of pH values. Some common examples of these surfactants are described in U.S. Patents 2,082,275, 2,702,279 and 2,555,082, incorporated herein by reference. Suitable zwitterionic surfactants have the formula R N C f-R Y I I wherein R Is an alkyl radical containing from about 8 to about 22 carbon atoms, R 2 and R 3 contain from about 1 to about 3 carbon atoms, R is an alkylene chain containing from about 1 to about 4 carbon atoms, X is selected from the group consisting of hydrogen and a hydroxyl radical, Y is selected from the group consisting of carboxyl and sulfonyl radicals and wherein the sum of the R 1 R 2 and R 3 radicals Is from about 14 to about 26 carbon atoms. Amphoteric and ampholytic surfactants which can be either cationic or anionic depending upon the pH of the system are represented by detergents such as dodecyl-beta-alanine, N-alkyltaurines such as the one prepared by reacting dodceylamine with sodium Isethionate according to the teaching of U.S. Patent 2,658,072, N-higher alkylaspartic acids such as those produced according to the teaching of U.S. Patent 2,438,091, and the products sold under the trade name "Mir-nol" and described In U.S. Patent 2,528,378, said patents being Incorporated herein by reference, Additional surfactants useful in the present Invention can be found in McCutcheon's Detergents and Emulsiflers, North American Ed. pages 317-324 (1986), incorporated herein by reference, propylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl -4. 26- The cleaning compositions of the present invention can optionally contain, at their art-established ,ivels, materials which are conventionally used in skin cleansing compositions. Conventional antibacterial agents and sanit zers can t included in the skir, cleansing compositions at levels of from about to about rypical antibacterial sanitizers which are suitable for use herein include 3,4-di- and 3,4',5'-tri-bromosalicylanilides; 4,4'-dichloro-3-(trifluoromethyl)carbanilide; 3,4, 41-trichlorocarbanilide and mixtures of these materials, Use of 1o these and related materials in skin cleansing compositions is described in more detail in Reller, et al., U.S. Patent 3,256,200, issued June 14, 1966, incorporated herein by reference. Nonionic emollients can be included as skin conditioning ag;nts in the skin cleansing compositions of the present invention at levels up to about 10%. Such material- include for example, mineral oils, paraffin wax having a melting point of from about 100o F to about 170 0 F, fatty sorbitan esters (see U.S. Patent 3,988,255, Seiden, issued October 26, 1976, incorporated by reference herein), lanolin and lanolin derivatives, esters such as Isopropyl myristate and triglycerides such as coconut oil or hydrogenated tallow. Free fatty acid, such as coconut oil fatty acid, can be added Sto the composition herein at levels up to about 10% to inprove the volume and qjality (creaminess) of thee ather produced by the compositions Perfumes, dyes and pigments can also be incorporated into preferably used at levels of from about 0.5% to and dyes and pigments are preferably used at levels of from about 0.001% to -x F30 about A particularly preferred optional ingredient Is a cationic or nonionic polymeric skin feel aid. Reduced skin Irritation benefits of both types of polymers are set out in "Polymr JR for Skin Care" Bulletin, by Uf.an carbide, 197 7 The catnor.cs are preferred over the nonlonics, for use herein, because they provide n 2 -Ln--U-LnM-n 2 urn a na OH OH CH CH I I 1 3 3 CH 2 -CH-CH 2 -0-C-CH-2-O-CH 2 H-OH S- 27 better skin feel benefits. Examples of the cationic polymers and the nonionic polymers useful for this purpose are set out below. The amount of polymeric skin feel aid found useful in the present invention is from about 0.5% to about preferably from 5 about 0.1% to about and more preferably from about 0.1% to about of the composition. i A particularly preferred skin feel aid is cationic (quaternized) guar gum, Jaguar C-14-S. from Celanese Corp. Other types of high molecular weight polymeric skin feel agents useful herein include nonionic guar gums, Merquats 100 and 550, made by Merck Co., Inc.; UCARE polymer JR-400, made by Union Carbide Corp.; Mirapol A15 made by Miranol i Chemical Company, Inc.; and Galactasol 811, made by Henkel, Inc. The nonionic polymers found to be useful as skin feel aids include the nonionic polysaccharides, nonionic hydroxypropyl guar gums, sold by Celanese Water Soluble Polymers;, a Division of Celanese Corp. A preferred nononic hydroxypropyl R guar gum material is Jaguar HP-60 having hydroxypropyl molar substitution of about 0.6. Another class of useful nonionic skin feel aids include cellulosic nonionic polymers, hydroxyethylcellulose and carboxymethylcellulose. In addition to the aforementioned components, optional humectants, thickening agents, preservatives, alkaline agents, the skin conditioning propoxylated glycerol derivatives, or cosmetic adjuvants may also be used in the skin cleansing compositions. Skin cleansing compositions formulated as toilet soap bars Sj 30 generally comprise from about 50% to about 90% Rurfactant. Moisture is generally present at levels of from about 5% to about Skin cleansing compositions formulated as liquids generally comprise from about 10% to about 30% surfactant and from about to about 90% water. Skin cleansing compositions formulated as pastes generally comprise from about 20% to about 60% surfactant and from about 30% to about 50% water. Pastes and liquids will boxyvinyl polymers (Carbopols' sold by B. h. Uoodrich Lompany, such polymers are described in detail in U.S. Patent 2,798,053, Brown, issued July 2, 1957, incorporated herein by i: 28 also generally contain organic thickening agents such as natural gums and polymers. Examples of soap-based toilet bar compositions are found in U.S. Patent 3,567,749, Megsc- at al., issued April 27, 1971, incorporated herein by reference. Examples of synthetic-based toilet bars which can be used In preparing compositions of the present inventiw- are found in U.S. Patent 2,987,484, Lundberg et al,, issued June 6, 1961, incorporated by reference herein. Other examples of soap/synthetic-based toilet bars are found in U.S. Patent 3,070,547, Chaffee, issued December 25, 1962 and U.S. Patent 3,376,229, Haas e, al., issued April 2, 1968, incorporated herein by reference. Examples of soap-based liquid cleansing compositions which can be used in preparing liquid compositions of the present invention are found in U.S. Patent 4,310,433, Stiros, issued January 12, 1982, incorporated herein by reference. Examples of synthetic-based liquid cleansing compositions which can be used in preparing compositions of the present invention are found in U.S. Patents 4,338,211, Stiros, issued June 6, 1982, incorporated herein by reference. Paste compositions can be made by appropriate reduction in the levels of water in the compositions of U.S. Patents 4,310,433 and 4,338,211. The skin cleansing compositions of this invention can also be formulated into a pressurized aerosol mousse composition. The mousse composition contains from about 88% to about 97%, pref- Serably from about 90% to about 96%, of a solution type of formulation (that has been concentrated), and from about 3% to about j 12%, preferably from about 4% to about 10%, of a propellant. i Preferred surfactants useful in these compositions are described 30 in European Patent Application 0194097, Schmidt et al., published September 10, 1986, incorporated herein by reference. A particularly preferred propellant is a mixture of butane, Isobutane, and propane, known commercially as Propellant A46, made by Phillips Chemical Company, a subsidiary of Phillips Petroleum Company. The skin cleansing compositions of the present invention preferably also comprise a substantivit ent to jirevent wash-off 'I it~i -29and to assure deposition of the tocopherol sorbate onto the skin, Suitable substantivity agents are guar gum and Polymer JR. Combination Actives Sunscreens Optimum protection against sun damage can be obtained by using a combination of the nori-sunscreening photoprotection agent of the present invention together with sunscreens. The photoprotecting capability of tocopherol sorbate is primarily against UVB radiation. Thus, the combination of tocopherol sorbate with a UVA sunscreen would be most desirable. Additional UVB protection may also be included in such compositions. The inclusion of surscreens in compositions of the present invention at low levels will not significantly reduce the tanninj response of the user but will enhance immediate protection against acute UV damage. A wide variety of conventional sunscreening agents are suitable for use in combination with tocopherol sorbate. Segarin, et al., at Chapter Vil, pages 189 et seq., of Cosmetics Science and Technology, disclose numerous suitable agents. Specific suitable sunscreening agents include, for example: p-Aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic acid) f Anthranilates o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters); Salicylates (amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters); Cinnamic acid derivatives (menthyl and benzyl esters, a-phenyl cinnamonitrile; butyl cinnamoyl pyruvate); Dihydroxycinnamic acid derivatives (umbeliiferone, methylumbelliferone, methylaceto-umbelliferone); Trihydroxycinnamic acid derivatives (esculetin, methylesculetin, daphnetin, and the glucosides, esculin and daphnin); Hydrocarbons (diphenylbutadiene, stilbene); Dibenzalacetorie and benzalacetophenone; Naphtholsulfonates (sodium salts of 2-naphthol-3 ,6-disulfonic and of 2-naphthol-6,8-disulfonic acids); Dihydroxy-naphthoic acid and its salts; 0- and p- Hydroxybiphenyldisulfonates; Coumarin derivatives (7-hydroxy, ing of octamethylcyclotetrasiloxane, decamethylcyclopentasioxane, dodlecamethyicyclohexasiloxane, cyciomethicone, and hexamethyldlisiloxane in a mixture with one or more non-volatile 7-methyl, 3-phenyl); Diazoles k2-acetyI-3-bromoindlazole, phenyl benzoxazole, methyl naphthoxazole, various aryl benzothiazoles); II Quinine salts (bisulfate, sulfate, chloride, oleate, and tannate); I'Quinoline derivatives (8-hydroxyquinoline salts 2-phenylquinoline); Hydroxy- or methoxy-substituted benzophenones: Uric Ii and vilouric acids; Tannic acid and its derivatives hexaethylether); (Butyl carbityl) (6-propyl piperonyl) ether; H ydroqulnone; Benzophenones (Oxybenzene, Sulisobenzone, Dioxybenzone, Benzoresorcinol, 2 4'-Tetrahydroxybenzophenone, 2, 2'-Dihydroxy-4 ,4'-dimethoxybenzophenone, Octabenzone; 4-1 sopropyld~benzoylmethane; Butyimethoxydibenzoylmethane; Etocrylene; and 4-isopropyl-di-benzoylmethane. Of these, 2-ethyihexyl p-methoxycinnamate, 4 ,4'-t-butyi methoxydibenzoyimethane, 2-hydroxy-4-methoxybenzophenDne, octyl dlimethyl p-amlnobenzoic acid, dligailoyltrioleate, 2,2d Ihyd roxy-4-methox yben zop he none, ethyl 4- [bis(hydroxypropyl) Iamlnobenzoate, 2-ethyihexyl 2 -cyano-3 ,3-d Ipheny lac ryilate, 2ethyihexyl salicylate, glyceryl p-aminobenzoate, 3,3 cyclohexyl salicylate, methyl anthranilate, p-dimethy lamlInobenzoic acid or aminobenzoate, 2-ethyihexyl p-dimethylaminobenzoate, acid, 2-(p-dimethylaminophenyi benzoxazoic acid and mixtures of these compounds,.are'' particularly useful. Preferred sunscreens useful In the compositions of the present Invention are 2-ethyihexyl p-methoxycinnamate, butyl methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone,4 octyl dimethyl p-aminobenzoic acid and mixtures thereof. A safe and photoprotectively effective amount of sunscreen may be used In the tocopherol sorbate compositions of the present Invention. By "safe and photoprotectivell is meant an amount sufficient to provide photoprotection 'when the composition is applied but not so much as to cause any side effects or skin reactions. The sunscreening agent must also be compatible with the tocopherol sorbate. By "compatible" Is meant that the sunscreening agent must be capable of being commingled with tocopherol sorbate in a manner such that there is no Interaction 31 which would substantially reduce the efficacy of the composition for photoprotection. Generally from about 1% to about preferably from about 2% to about 10%, of the composition may comprise a sunscreening agent. Exact amounts will vary depending upon the sunscreen chosen and the desired Sun Protection Factor (SPF). SPF is a commonly used measure of photoprotection of a sunscreen against erythema. This number is derived from another parameter, the minimal erythemal dose (MED). MED is defined as the "lease zxpoure dose at a specified wavelength that will elicit a delayed erythema response." The MED indicates the amount of energy reaching the skin and the responsiveness of the skin to the radiation. The SPF of a particular photoprotector is obtained by dividing the MED of protected skin by the MED of unprotected skin. The higher the SPF, the more effective the agent in preventing sunburn. The SPF value tells how many times longer a person can stay In the sun with use of the i~i sunscreen (compared to a person with unprotected skin) before Sthat person will experience 1 MED. For example, utilizing a i 2 sunscreen with an SPF of 6 will allow an individual to stay In the sun six times longer before receiving 1 MED. As the SPF value of a sunscreen increases, the less chance exists for development of tanning of the skin. Commercially available sunscreening products have SPF values ranging from 2 to 34. Tocopherol :-'rbate's photoprotecting capability against erythema can also' be measured. Tocopherol sorbate provides erythema reduction aquivalent to an SPF-2 sunscreen. When an SPF-2 sunscreen agent is utilized with tocopherol sorbate for protection against sunburn, the combination provides protection j 30 equivalent to an SPF-4 sunscreen. It is much more difficult to measure the benefits achieved by the use of tocopherol sorbate against long-term effects of UV exposure, such as premature aging of the skin. One method for measuring photo-induced wrinkling of skin is disclosed in "An Animal Model of Solar-Aged Skin: Histologic;l, Physical, and -32- Visible Changes in UV-Irradiated Hairless Mouse Skin", Bissett et al., Photochem. Photobiol., 46 pp. 367-378 (1987). Also particularly useful in the present invention are sunscreens such as those disclosed in Sabatelli, U.S. Patent Application Serial No. 054,085 (filed June 2, 1987) and Sabatelli et al., U.S. Patent Application Serial No 054,046 (filed June 2, 1987). The sunscreening agents disclosed therein have, in a single molecule, two distinct chromophore moieties which exhibit different ultra-violet radiation absorption spectra. One of the chromophore moieties absorbs predominantly in the UVB radiation range and the other absorbs strongly in the UVA radiation range. These sunscreening agents provide higher efficacy, broader UV absorption, lower skin penetration and longer lasting efficacy relative to conventional sunscreens. Preferred members of this class of sunscreening agents are 4-N,N-(2-ethylhexyl) methylaminobenzoic acid ester of 2,4dihydroxybenzophenone; N,N-di-(2-ethylhexyl)-4-aminobenzoic acid ester With 4-hydroxydibenzoylmethane; 4-N,N-(2-ethylhexyl) methylaminobenzoic acid ester with 4-hydroxydibenzoylmethane; 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester of 2-hydroxy- 4-(2-hydroxyethoxy)benzophenone; 4-N,N-(2-ethylhexyl) methyli aminobenzoic acid ester of 4-(2-hydroxyethoxy) dlbenzoylmethane; j "i N-N-di-(2-ethylhexyl)-4-aminobenzoic acid ester of 2-hydroxy-4- (2-hydroxyethoxy) benzophenone; and N,N-di-(2-ethylhexyl)-4aminobenzoic acid ester of 4-(2-hydroxyethoxy)dlbenzoylmethane and mixtures thereof. The compositions of the present invention, with or without sunscreens may also be formulated as shampoos, conditioners, S mousses or other hair care products. It is known that UV S 30 radiation damages hair and the photoprotecting agents of the present invention may minimize such damage. Furthermore such formulations will provide a means for applying the photoprotecting agents of the present invention onto the scalp, which is also susceptible to UV damage. Any compatible art-recognized hair S 35 care formulations can be used with tocopherol sorbate added at a a.o ji 33 level of from about 1% to about If desired, a sunscreen may also be included at from about 1% to about An agent may also be added to any of the compositions of the present invention to improve the skin substantivity of those compositions, particularly to enhance their resistance to being washed off by water, or rubbed off. A preferred agent which will provide this benefit is a copolymer of ethylene and acrylic Sacid. Compositions comprising this copolymer are disclosed in U.S. Patent 4,663,157, Brock, issued May 5, 1987, which Is i{ 10 incorporated herein by reference. The disclosed skin substantivity agent comprises the polymeric form of two monomers, ethylene and acrylic acid, to yield the following: (CH CH 2 )(CH 2 CH)y C 0 C=O OH wherein the ratio of x:y is from about 1:24 to about 1:9, and wherein the weight average molecular weight of the molecule is from about 3500 to about 4500, preferably from about 4000 to jj about 4300. These copolymers are preferably included in an oil-in-water emulsion sunscreen composition comprising: a) from about 1% to about 20% of tocopherol sorbate plus an optional oil-soluble sunscreen; b) from about 0.25% to about 3% of the ethylene-acrylic acid copolymer as described above; c) from about 2% to about 10% of an emulsifier; and d) from about 70% to about 90% of water wherein the ratio of photoprotecting agents to the copolymer is from about 12:1 to about 15:1. Sunscreenlng agents which are particularly useful in combination with these copolymers are 2-ethylhexyl p-methoxycinnamate, butyl methoxydlbenzoyl- 0 methane, 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoic acid and mixtures thereof. Anti-Inflammatory Agents In a preferred photoprotection composition of the present invention, an anti-inflammatory agent is included as an active along with tocophero' sorbate. The inclusion of an anti- SInflammatory agent enhances the photoprotection benefits of the compositions. The anti-inflammatory agent protects strongly In the UVA radiation range (though it may provide some UVB protection as well), while tocopherol sorbate protects strongly in the UVB radiation range. Thus the combination provides broad protection. The topical use of anti-inflammatory agents to reduce the effects of acute exposure, erythema, to UV radiation is known. However, it has now been discovered that the chronic use of anti-inflammatorles also greatly reduces photo-aging of the skin resulting from chronic exposure to UV radiation. It has also been dclcovered that the combination of an anti-inflammatory agent and tocopherol sorbate provides greater photoprotection than is provided by each active alone. Furthermore, the combination provides greater photoprotection than Is provided by the sum of the effects of each active alone. By greater photoprotection is meant both reduction of acute effects of UV exposure, erythema and reduction of chronic effects of UV exposure, eg., premature wrinkling and sagging of the skin. A safe and photoprotectively effective amount of an antiinflammatory agent may be added to the compositions of the present invention. By "safe and photoprotectively effective" amount is meant an amount sufficient to provide photoprotection when the composition is properly applied, but not so much as to cause any side effects or adverse skin reactions; generally from about 0.1% to about 10%, preferably from about 0.5% to about of the composition. The exact amount of anti-inflammatory agent to be used in the compositions will depend on the particular anti-inflammatory agent utilized since such agents vary widely in potency. Steroidal anti-inflammatory agents, Including but not limited to, corticosteroids such as hydrocortisone, hydroxyltriamclnolone, alpha-methyl dexamethasone, dexamethasone-phosphate, beclomethasone diproplonate, clobetasol valerate, desonide, desoxymethasone, desoxycorticosterone acetate, dexamethasone, dichlorlsone, diflorasone diacetate, diflucortolone valerate, fluadrenolone, fluclorolone acetonide, fludrocortisone, flumethasone plvalate, fluosinolone acetonide, fluocinonide, flucortine butylester, fluocortolone, fluprednidene (fluprednylidene) acetate, flurically set forth in U.S. Patents 2,486,921, 2,486,922 and 2,396,278, incorporated herein by reference. An important type of useful anionic surfactants are soaps. Soaps wh)ch can be used as the surfactant in the present S- 35 andrenolone, halcinonide, hydrocortisone acetate, hydrocortisone butyrate, methylprednisolone, triamcinolone acetonide, cortisone, cortodoxone, flucetonide, fludrocortisone, difluorosone diacetate, fluradrenolone acetonide, medrysone, amcinafel, amcinafide, betamethasone and the balance of its esters, chloroprednisone, chlorprednisone acetate, clocortelone, clescinolone, dichlorisone, difluprednate, flucloronide, flunisolide, fluoromethalone, fluperolone, fluprednisolone, hydrocortisone valerate, hydrocortisone I cyclopentylpropionate, hydrocortamate, meprednisone, paramethasone, prednisolone, prednisone, beclomethasone dipropionate, d trlamcinolon.. 3and mixtures thereof may be used. The preferred i steroidal anti-inflammatory for use In the present invention Is hydrocortisone. A second class of anti-inflammatory agents which is useful in the compositions of the present invention includes the non-steroidal anti-inflammatory agents. The variety of compounds encompassed by this group are well-known to those skilled In the art. For detailed disclosure of the chemical structure, synthesis, j side effects, etc. of non-steroidal anti-inflammatory agents, i 20 reference may be had to standard texts, Including Anti-Inflammatory and Anti-Rheumatic Drugs, K. D, Rainsford, S Vol. 1-111, CRC Press, Boca Raton, (1985), and Anti-inflammatory Agents, Chemistry and Pharmacology, 1. R. A. Scherrer, et al., Academic Press, New York (1974), Incorporated herein by reference. i Specific non-steroidal anti-inflammatory agents useful In the composition of the present invention include, but are not limited to: S1) the oxicams, such as piroxicam, isoxicam, tenoxican, sudoxicam, and CP-14,304; 2) the salicylates, such as aspirin, disalcid, beiorylate, trilisate, safapryn, solprin, diflunisal, and fendosal; 3) the acetic acid derivatives, such as ddclofena., i fenclofenac, Indomethacin, sulindac, tolnetin, Isoxepac, S I' 'I -36zomepirac, clidanac, oxepinac, and felbinac; 4) the fenamates, such as mefenamic, meclofenamic, flufenamic, niflumic, and tolfenamic acids; 5) the propionic acid derivatives, such as ibuprofen, naproxen, benoxaprofen, flurbiprofen, ketoprofen, fenoprofen, fenbufen, indoprofen, pirprofen, carprofen, oxaprozin, pranoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen, and tiaprofenic; and 6) the pyrazoles, such as phenylbutazone, oxyphenbutazone, feprazone, azapropazone, and trimethazone. Mixtures of these non-steroidal anti-inflammatory agents may also be employed, as well as the pharmaceutically-acceptable salts and esters of these agents. For example, etofenamate, a flufenamic acid derivative, is particularly useful for topical use. Of the nonsteroldal anti-inflammatory agents, ibuprofen, naproxen, flufenamic acid, mefenamic acid, meclofenamic acid, piroxicam and felbinac are preferred, and ibuprofen, naproxen, and flufenamic 2b acid are most preferred. Another class of anti-inflammatory agents which are usefuil in the present invention are the anti-inflammatory agents disclosed in U.S. Patent Application Serial No. 879,863, Loomans et al., filed June 27,, i986. This application discloses a class of nonsteroidal anti-Inflammatory compounds which comprise specificallysubstituted phenyl compounds, especially substituted 2,6-di-tertbutyl phenol derivatives. For example, compounds selected from 4-(4'-pentyn-3 '-one)-2,6-di-t-butylphenol; 4-(5'-hexynoyl)-2,6dl-t-butylphenol; -methyl-5 -hexynoyl)-2,6-di-tbutylphenol; 4- R)-(+)-3'-methyl-5'-hexynoyl)-2,6-di-t-butylphenol; and 4-(3',3'-dimethoxy proplonyl)-2,6-d-t-butylphenol are useful in the present Invention. Yet another class of anti-inflammatory agents which are useful in the present invention are those disclosed in U.S. Serial No. 051 ,14416, Mueller, filed May 18, 1987. This application S. discloses compounds and diastereomeric mixtures of specific 2-naphthyl-containing ester compounds, especially naproxen ester i :i per mole OT p erilui. uiIl '7 n this type include Igepal CO-630, marketed by the GAF Corpor ation; and Triton X-45, X-114, X-100, and X-102, all marketed by the Rohm Haas Company. 37 and naproxol ester compounds, having two or more chiral centers. For example, compounds selected from (S)-naproxen-(S)-2-buty! ester, (S)-naproxen-(R)-2-butylester, (S)-naproxol-(R)-2-methyl hutyrate, (S)-naproxol-(S)-2-methy butyrate, diasteromeric mixtures of (S)-naproxen-(S)-2-butyl ester and (S)-naproxen- (R)-2-butyl ester, and diasteromeric mixtures of (S)-naproxol- (R)-2-methyl butyrate and (S)-naproxol-(S)-2-methyl butyrate are useful in the present Invention. Finally, so-called "natural" anti-inflammatory agents are useful in the present invention. For example, candellla wax, alpha-bisabolol, aloe vera, Manjistha (extracted from plants In the genus Rubia, particularly Rubla Cordifolia), and Guggal (extracted from plants in the genus Commiphora, particularly Commiphora Mukul), may be used. An even more preferred composition of the present invention comprises tocopherol sorbate, a sunscreen, and an anti-in-, flammatory agent together for photoprotection. Such a composition comprises from about 1% to about 10%, preferably from f about 2% to about 5% tocopherol sorbate, from about 1% to about 15%, preferably from about 2% to about 10% of a sunscreen, and from about 0.2% to about preferably from about 0.5% to about 2% of an anti-inflammatory agent. This combination gives protection broader than that provided with each photoprotectoh alone. Furthermore, the combination provides greater photoprotection than Is provided by the sum of the effects of each active alone. By greater photoprotection is meant both reduction of acute effects of UV exposure, erythema, and reduction of chronic effects of UV exposure, premature wrinkling and i3 sagging of the skin. In the compositions of the present Invention other radical scavenging compounds may be used in combination with tocopherol sorbate. For example, ascorbic acid (Vitamin C) and :ts salts, tocopherol (Vitamin other tocopherol esters, butylated hydroxy benzoic acids and their salts, 6-hydroxy-2,5,7,8-tetra- S 35 methylchroman-2-carboxylic acid (commercially available under the tradename TroloxR), gallic acid and its alkyl esters, especially 38 propyl gallate, uric acid and its salts and alkyl esters, sorbic acid and its salts, the ascorbyl esters of fatty acids, amines N,N-diethylhydroxylamine, aminoguanidine), sulfhydryl compounds glutathione) and dihydroxyfumaric acid and its salts. Each of these compounds has photoprotecting capabilities. However, the use of tocopherol sorbate alone in the present Invention is preferred, From about 1% to about 5% of these radical scavenging compounds may be used in the present invention in combination with the levels of tocopherol sorbate taught herein. Exact amounts will vary depending on which particular compound is used as these compounds vary somewhat in potency. Method For Preventing Deleterious iffects Caused By UV Exposure 1 15 The present invention further relates to a method for protecting the skin of humans and lower animals from the deleterious i effects of UV radiation. Such protection by tocopherol sorbate Sextends not only to damage resulting from acute UV exposure, e.g. erythema, but also to damage resulting from chronic UV exposure, e.g. photoaging. Such a method comprises applying to the skin of the human j or lower animal a safe and photoprotectively effective amount of tocopherol sorbate. This may be accomplished by using a composttion comprising tocopherol sorbate as described in the present application. The term "safe and photoprotectively effective amount", as used herein, means rn amount sufficient to substani tially reduce the deleterious effects of UV-radlation to skin but not so much as to cause any side effects or adverse skin reactions, Typically a safe and photoprotectively effective amount j 30 Is from about 0.01 mg to about 1.0 mg, preferably from about 0.05 mg to about 0.5 mg, tocopherol sorbate per cm 2 skin, The tocopherol sorbate may be simply spread or sprayed onto the skin or may preferably be rubbed Into the skin to enhance penetration. The tocopherol sorbate works best if applied prior to or S 35 concomitantly with UV exposure. It may also be applied up to about 30 minutes after UV exposure. However, unlike typical -39 J sunscreens, which must remain as a coating or, the skin throughout UV exposure, the application of topherol sorbate may be done up to four hours prior to nxoosuie. This is because the active agent penetrates the skin to work and thus is not as susceptible to rub-off, wash-off or wear-off. For protection against acute damage from UV-radiation, application of tocopherol sorbate just prior to exposure is preferred. For protection i against chronic damage from UV-radiation, application of tocopherol sorbate several times daily; generally from about 2 ;mes to about 5 times, preferably 2 times daily, is preferred. A preferred method of the present Invention for preventing deleterious effects caused by UV exposure Involves applying both a safe and photoprotectively effective amount of tocopherol sorbate and a safe and photoprotectively effective amount of a sunscreening agent to the skin simultaneously. By simultaneous application is meant applying the agents to the skin at the same situs on the body at about the same time. Though this can be accomplished by applying one of these agents to the skin after application of the other, preferably a composition comprising Dot agents commingled is applied to the skin, By "safe and photoprotectively effective amount" of sunscreening agent Is meant an amount sufficient to substantially reduce the deleterious effects of UV-radiation to skin but not so much as to cause any side effects or adverse skin reactions; generally from about 0.01 mg to about 1.0 mg, preferably from about 0.05 mg to about 0.5 mg, of sunscreening agent per cm of skin. Preferably, the sunscreening agent used In the present method is selected from the group consisting of 2-ethylhexyl p-methoxycinnamate; butyl methoxydibenzoylmethane; 2-hydroxy- 4-methoxybenzophenone; octyldimethyl p-aminobenz6lc acid; the 4-N,N-(2-ethylhexyl)methylaminobenzolc acid ester of 2,4-dihydroxybenzophenone; the N,N-di-(2-ethylhexyl)-4-aminobenzolc acid ester of 4-hydroxydlbunzoylmethane; the 4-N,N-(2-ethylhexyl)methylamlnobenzolc acid ester of 4-hydroxy dlbenzoylmethane; the 4-N,N-(2-ethylhexyl)methylamlnobenolc acid ester of 2-hydroxy-4-(2-hydroxyethoxy)benzophenone; the 4-N,N-(2- Care" Bulletin, by Union Carbide, 1977. The catioriics are preferred over the nonionics, for use herein, because they provide ethylhexyl) methylaminobenzoic acid ester of (2-hydroxyethoxy)dibenzoylmethane; the N-N-di-(2-ethylhexy!)-4-amino benzoic acid ester of 2-hydroxy-4-(2-hydroxyethoxy)benzophenone; the N,N-di- (2-ethylhexyl)-4-amino benzoic acid ester of 4-(2-hydroxyethoxy)dibenzoyl methane, and mixtures thereof. The tocopherol sorbate and sunscreening agent may be simply spread over the skin, or rub into the skin to enhance penetration of the tocopherol sorbate. The actives are applied in conjunctior with UV exposure, prior to, during or after UV exposure. For protection against acute damage from UVradiation, application of the actives just prior to exposure is sufficient. For protection against chronic damage from UVradiation, application several times daily, about 2 times daily, is preferred. The use of anti-inflammatory agents for inhibiting adverse acute effects of UV exposure, erythema, is known. However, it has now beern discovered that anti-inflammatory agents may be used to inhibit adverse chronic effects of UV exposure, premature wrinkling and sagging of the skin. Th'u, the present invention relates to a method for protecting the skin from chronic effects of UV exposure comprisint chronic applic .,on to the skin of a safe and photoprotectively effective amount of an anti-inflammatory agent. The term "safe and photoprotectively effective amount" as used herein, means an amount 2; sufficient to substantially reduce the deleterious effects of UVradiation to the skin but not so much as to cause any side effects or atdverse skin reactions. Typically a safe and photoprotectively effective amount is from about 0.005 mg to about 0.5 mg, preferably from about 0.01 mg to about 0.1 rag, anti-inflammatory agelti per cm 2 skin. By "chroiic application" Is meant application io the skin several times daily, generally from about 2 times to about 5 times, preferably 2 times daily, for an extended period of time greater than seven, preferably greater than 10, days. Preferably this regimen of application is continued for as long as the user chronically exposes him or herself to damaging UV SraT ition. This may comprise application over a period of several I t)Ut 10 dLUUL ratOi pastes generally comprise from about 20% to about 60% surfactant and from about 30% to about 50% water. Pastes and liquids will ;~inl'1uCL "I 41 days, months or longer. The anti-inflammatory agent may be simply spread over the skin or may preferably be rubbed into the skin to enhance penetration. Preferably the anti-inflammatory agent used in the present method is selected from the group consisting of hydrocortisone, Ibuprofen, naproxen, flufenamic acid, mefenamic acid, meclofenamic acid, piroxicam, felbinac, 4-(4'-pentyn-3'-one)-2,6-di-tbutylphenol; 4-(5'-hexynoyl)-2,6-di-t-butylphenol, methyl-5'-hexynoyl)-2,6-di-t-butylphenol, hexynoyl -2,6-di-t-butylphenol, 4-(3',3'-dimethoxy propionyl)- 2,6-di-t-butylphenol, Manjistha, Guggal, and mixtures thereof. A more preferred i hod of the present invention for prevent- Ing deleterious effects caused by UV exposure involves applying both a safe and photoprotectively effective amount of tocopherol sorbate and safe and photoprotectively effective amount of an anti-inflammatory agent to the skin simultaneously. By "simultaneously" is meant application of the agents to the skin at the same situs on the body at about the same time. Though this can be accomplished by applying one of these agents to the skin after 21) application of the other, preferably a composition comprising both agents commingled is applied to the skin. By "safe and photoprotectively effective amount" of each agent is meant an amount sufficient to substantially reduce the deleterious effects of UVradiation to skin but not much as to cause any side effects or adverse skin reactions; generally from about 0.005 mg to about mg, preferably from about 0.01 mg to about 0.1 mg, antiinflammatory agent per cm skin, and from ahout 0.01 mg to about 1.0 mg, preferably from about 0.05 mg to about 0.5 mg, tocopherol sorbate per cm skin. The tocopherol sorbate and anti-inflammatory agent may be simp'y spread over the skin or may preferably be rubbed Into the skin to enhance penetration. Unlike with tocopheroi' sorbate alone, the combination of tocopherol sorbate plus anti-inflammatory agent are applied In conjunction with UV exposure, prior to, concomm'itantly with, or after UV ex'osuro. More specifically, the combination may be applied up to about 4 hours prior to UV exposure, up to I' T a =uu)iuldry oT rniips retroleum L.ompany. The skin cleansing compositions of the present invention preferably also comprise a substantivit, ;.-ent to jprevent wash-off i.l- r r 3%1a 42 about 30 minutes after UV exposure, or any time in between. This is because the anti-inflammatory agent works to minimize adverse reactions in the skin even if applied after UV posure. For protection against acute damage from UV-radiation, application of tocopherol sorbate and the anti-inflammatory agent just prior to exposure, or immediately following exposure, is sufficient. For protection against chronic damage from UV-radiation, application of tocopherol sorbate and the anti-inflammatory agent several times daily, from about 2 times to about 5 times, preferably 2 times daily is preferred. Yet another method of the present invention for preventing deleterious effects caused by UV exposure involves applying a safe and photoprotectively effective amount of tocopherol sorbate, a safe and photoprotectively effective amount of an anti-inflammatory agent, and a safe and photoprotectively effective amount of sunscreening agent to the skin simultaneously. By "simultaneously" is meant application of the agents to the skin at the same situs on the body at about the same time. Though this can be accomplished by applying the agents to the skin sequentially (one after the other), preferably a composition comprising all three agents commingled Is applied to the skin. By "safe and photoprotectively effective amount" of each agent Is meant an amount* sufficient to substantially reduce the deleterious effects of UVradiation to skin but not so much as to cause any side effects or 25 adverse skin reactions; generally from about 0.01 mg to about 1 mg, preferably from about 0.05 mg to about 0.5 mg tocopherol 2 sorbate per cm skin, from about 0.005 mg to about 0.5 mg, preferably from about 0.01 mg to about 0.1 mg anti-inflammatory 2 agent per cm skin, and from about 0.01 mg to about 1 mg, preferably from about 0.05 mg to about 0.5 mg sunscreening 2 agent pe, cm skin. The tocopherol sorbate, anti-inflammatory agent, and sunscreening agent may be simply spread over the skin or may preferably be rubbed into the skin to enhance penetration. The combination is applied In conjunction with UV ex- 35 posure, prior to, concommitantly with, c fter UV exposure. More specifically, the combination may be applied up to *0 #0 Op 01 00 0000 000 000'. 0000 00 00 0 49 pO 4 O; 0 0 4 0 0* 2-naphthol-3,6-disulfonic and of 2-naphthol-6,8-disulfonic acids); Dihydroxy-naphthoic acid and its salts; o- and p- Hydroxybiphenyldisulfonates; Coumarin derivatives (7-hydroxy, .A I I I-~ rr~ y 1 43 about 4 hours prior to UV exposure, up to about 30 minutes after UV exposure, or any time in between. For protection against acute damage from UV-radiation, application of tocopherol sorbate, the anti-inflammatory agent, and the sunscreening agent just prior to UV exposure is sufficient. For protection against chronic damage from UV-radiation, application of tocopherol sorbate, the anti-inflammatory agent, and the sunscreening agent several times daily, from about 2 times to about 5 times, preferably 2 times daily is preferred. The following examples further describe and demonstrate the preferred embodiments within the scope of the present invention. The examples are given solely for the purpose of illustration, and are not to be construed as limitations of the present invention since many variations thereof are possible without departing from its spirit and scope. All percentages and ratios herein are by weight, unless otherwise specified. EXAMPLF A moisturizing lotion is prepared by combining the following components utilizing conventional mixing techniques. Components Percent by Weight of Composition Water (purified) Carbomer viscosity control agents (commercially available in the Acritamer series from R.I.T.A. Corp,) Alkyl Parabens Glycerin Potassium Hydroxide Tetrasodium EDTA, Cetyl Alcohol Stearic Acid Glyceryl Stearate Polyoxyethylene Stearyl Alcohol (commercially available in the Brij series from ICI Americas, Inc.) 70.94 0.23 0.90 3.50 0.09 0.15 0.10 1.25 0.75 0.63 1.75 44 Coco-Caprylate/caprate 2.00 C 1 2 -C 15 Alcohol Benzoate (Finsolv TN 2.00 commercially available from Finetex, Inc.) Tocopherol Sorbate 2.00 Octyl Methoxycinnamate 7.50 Benzophenone-3 1.00 Octyl Dimethyl PABA 1.00 Dimethicone 0.30 Imidazolidinyl Urea 0.10 Ethylene Acrylate Copolymer 3.80 Tyrosine 0.10 This lotion may be topically applied to inhibit damage caused by acute or chronic UV exposure. Use of an amount of lotion sufficient to deposit about 0.5 mg/cm 2 of tocopharol sorbate, and about 0.5 mg/cm 2 of the sunscreening agents to the skin immediately prior to UV exposure Is appropriate. Substantially similar results are obtained if the lotion is applied to the skin up to 4 hours prior to UV exposure or up to 30 minutes after UV exposure. Substantially similar results are obtained if the octyl methoxyclnnamate, benzophenone-3, and octyl dimethyl PABA are ret placed, In whole or in part, with 2-ethylhexyl p-methoxycinnamate, butyl methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, and mixtures. thereof. EXAMPLE II A skin lotion is prepared by combining the following components utilizing conve.ntional mixing techniques. Component Percent by Weight i 30 Of Composition 4-M.N -(2-Ethylhexyl)methylamino 10.00 Benzolc Acid Ester of 4-(2-Hydroxyethoxy)- Diber,;yl Methane Water (purified) 47.54 Dimethyl Isosorbide 8.00 Dioctyl Malcate 8.00 C 1 2 1 5 Alcohol Benzoate (Finsolv TN-commercially 8.00 12-15 j& iII ai\inI. 'use metnoa ror measuring photo-induced wrinkling of skin is disclosed in "An Animal Model of Solar-Aged Skin: Histological, Physical, and Cetyl Alcohol 1.75 Polyoxyethylene Steeryl Alcohol (commercially 1.75 I 45 available fromn the Brij series from ICIInc.) AmGlycericas, Inc.)3.50 Ethyleneearic Acrylate Copolymer 3.80 GlyTocopherl Sorbate 2.00 Alkyl Parabens 0.90 Titanium Dioxide 0.40 CDetyl Alcohol 10.375 CarbPolyoxyethylene Stey control Alcoholgents (commercially 1.75 15 available in the rita ser seres from R.I.T.A Americasorp., Inc.) Stearic Acid 1.25 10 Glyceryl Stearate 1.13 ImdazoAlky dinyl Parabens 0.90 PoTitanium HDioxide 0.40 SDimethione 0.30 Carbomer viscosity control agents (commercially 0.23 available in the Acritamer series from R.I.T.A. Corp.) Imidazolidinyl Urea 0.10 jj Potassium Hydroxide 0.15 Tyrosine 0.10 Tetrasodium EDTA 0.10 i This lotion is useful for topical application to Inhibit damage I caused by acute or chronic UV exposure. Use of an amount of h lotion sufficient to deposit about 0.5 mg/crm of tocopherol sorbate, and about 0.5 mg/cm 2 of the sunscreening agents to the skin immediately prior to UV exposure is appropriate. Substantially i similar results are obtained if the lotion is applied to the skin up 4 hours prior to UV exposure or up to 30 minutes after UV exposure. Substantially similar results are obtained If the 4-N,N- (2-ethylhexyl)methylaminobenzoic acid ester of 4-(2-hydroxyethoxy)dibenzoylmethane is replaced, in whole or in part, with the 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester of 2,- 4-dihydroxybenzophenone, the N,N-di-(2-ethylhexyl)-4-aminobenzoic acid ester of 4-hydroxydibenzoylmethane, the 4-N,N-(2ethylhexyl)methylaminobenzoic acid ester of 2-hydroxy-4-(2- Shydroxyethoxy)benzophenone, the 4-N,N-(2-ethylhexyl)methyli j:i j i j :i i i i j rij 46 aminobenzoic acid ester of 4-(2-hydroxyethoxy)dibenzoylmethane, the N-N-di-(2-ethylhexyl) -4-aminobenzbic aid ester of 2hydroxy-4-(2-hydroxyethoxy)benzophenone, or the N,N-di-(2ethylhexyl) -4-aminobenzoic acid ester of 4-(2-hydroxyethoxy)-. dibenzoylmethane, and mixtures thereof. EXAMPLE III A suntan cream is prepared by combining the following components utilizing conventional mixing techniques. Component Percent by Weight 10 of Composition Mineral Oil 20.00 Octyl Palmitate 10.00 Glyceryl Isostearate 4.00 Octyl Methoxycinnamate 7.50 Oxybenzone 3.00 Polyethylene (AC-617-A,AC-6-A available 2.00 from Allied Chemical) Alkyl parabens 0.30 Glycerin 2.00 0 Tocopherol Sorbate 2.00 Ibuprofen 1.00 Water (purified) q.s. This cream is useful for topical application to Inhibit damage. caused by acute or chronic UV exposure. Use of an amount of 25 cream sufficient to deposit about 0.5 mg/cm 2 of tocopherol sorbate, about 0.5 mg/cm 2 of the sunscreening agents, and about 0.1 mg/cm 2 of ibuprofen to the skin immediately following UV exposure is appropriate. Substantially similar results are obtained if the cream is applied to the skin up to 4 hours prior to UV exposure or up to 30 minutes following UV exposure. Substantially similar results are obtained if the octyl methoxy cinnamate and the oxybenzone are replaced, in whole oF in part, with 2-ethylhexyl p-methoxycinnamate, butyl methoxydibenzoyl methane, 2-hydroxy-4-methoxybenzophenone, and mixtures thereof. invention, an anti-inflammatory agent is included as an active t along with tocopheroi sorbate. The inclusion of an anti- Sinflammatory agent enhances the photoprotection benefits of the compositions. The anti-inflammatory agent protects strongly in 47 Substantially similar results are obtained if the ibuprofen is replaced, in whole or in part, with hydrocortisone acetate, naproxen, flufenamic acid, mefenamic acid, meclofenamic acid, piroxicam, felbinar 4-(4 -pentyn-3'-one)-2,6-di-t-butylphenol, 4-(5'-hexynoyl)-2,6-di-t-butylphenol, hexynoyl-2,6-di-t-butylphenol, 4-(R)-(+)-3'-methyl-5'-hexynoyl- 2,6-di-t-butylphenol, 4-(3',3'-dimethoxypropionyl)-2,6-di-t-butylphenol, Manjistha, Guggal, and mixtures thereof. EXAMPLE IV A suntan stick is prepared by comibining the following components utilizing conventional mixing techniques, Component Percent by Weight of Composition Candelilla Wax 19.25 Ozokerite Wax 19.25 Petrolatum 19.25 Lanolin 15.00 Mineral Oil 14.85 Octyl Dimethyl PABA 7.00 i 20 Benzophenone-3 3.00 BHA (preservative: butylated hydroxy 0.05 i anisole) Propylparaben 0.10 j Tocopherol Sorbate 5.00 Flavor q.s. This stick is useful for topical application, for example to the lips, to inhibit damage caused by acute or chronic UV exposure. Use of an amount of stick sufficient to deposit about mg/cm 2 of tocopherol sorbate, and about 0.5 mg/cm 2 of the I] 30 sunacreening agents to the lip~s mmediately prior to UV exposure Is appropriate. Substantially similar results are obtained if the stick is applied up to 4 hours prior to UV exposure or up to minutes after UV exposure. Substantially similar results are obtained if the octyl dimethyl PABA and the benzophenone-3 are replaced, in whole or in part, with 2-ethylhexyl p-methoxycinnamate, butyl methoxy- -48 dibenzoylmethane, -roxy-4-methoxybenzophenone, and mixtures thereof. EXAMPLE V A low SPF suntan cream is prepared by combining the fol- S lowing components utilizing conventional mixing techniques. Component Percent by Weight of Composition Tetrasodium EDTA 0.05 Alkylparabens 0.30 Carbopol (polyacrylic acid polymer- 0,20 commercially available from B. F. Goodrich Chemical) Glycerin 2.00 Laureth-23 (polyethylene glycol ether of 3.00 lauryl alcohol) Sorbitan Stearate 1.50 Octyl Dimethyl PABA 3.00 Dimethicone 2.00 Stearyl Alcohol 6.00 Trlethanolamine 0.20 Tocopherol Sorbate 2.00 i Water (purified) q.s. t ""his cream is useful for topical application, to Inhibit damage i caused by acute or chronic UV exposure. Use of an amount of cream sufficient to deposit about 0.5 mg/cm 2 of tocopherol 1 sorbate, and about 0.5 mg/cm 2 of the sunscreening agents to the skin immediately prior to UV exposure is appropriate. Substantially similar results are obtained if the cream is applied to the skin up to 4 hours prior to UV exposure or up to minutes after UV exposure. 4 Substantially similar results are obtained if the octyl dimethyl PABA Is replaced, in whole or in part, with 2-ethylhexyl p-methoxycinnamate, butyl methoxydibonzoylmethane, 2-hydroxy- 4-methoxybenzophenone, and mixtures thereof. EXAMPLE VI A suntan aqueous face gel is prepared by combining the following components utilizing conventional mixing techniques. I ;j I- -Ui~ 49 Component Water (purified) Percent by Weight Of Composition 50.00 Aloe 38.00 Carbopol 1.00 Glycerin 3.00 Methylparaben 0.20 Triethanolamine 0.90 2-Phenyl-Benzimedoic Sulfonic Acid 2.00 Octoxynol-13 (ethoxylated alky! phenol 1.50 (C 8 H 17 )(C 6 H )(OC CCH 2 )nOH, n av. val. 13) Tocopherol Sorbate 2.00 Color and Fragrance q.s. This aqueous gel is useful for application to the face to inhibit damage caused by acute or chronic UV exposure. Use of an amount of gel to deposit about 0.5 mg/cm 2 of tocopherol sorbate to the face immediately prior to UV exposure is appropriate. Substantially similar results are obtained if the gel is applied to the face up to 4 hours prior to UV exposure or up to 30 minutes after UV exposure. EXAMPLE VII A suntan gel is prepared by c'ombining the following components utilizing conventional mixing techniques. Component Percent by Weight Ozokerite Wax Poraffin Petrolatum Isopropyl Myristate Mineral Oil Octyl Dimethyl PABA Propylparaben BHA Tocopherol Sorbate Naproxen Fragrance and Color of Composition 10.00 10.00 10.00 5.00 58.00 2.50 0.10 0.05 2.00 2.00 q.s. 1 so 50 This suntan gel is useful for topical application to inhibit damage caused by acute or chronic UV exposure. Use of an amount of gel to deposit about 0.5 mg/cm 2 of tocopherol sorbate, about 0.5 mg/cm 2 of the sunscreening agent, and about 0.1 mg/cm' of naproxen to the skin immediately following UV exposure is appropriate. Substantially similar results are obtained if the gel is applied to the skin up to 30 minutes after UV exposure or up to 4 hours prior to UV exposure. Substantially similar results are obtained If the octyl dimethyl PABA is replaced, in whole or in part, with 2-ethylhexyl p-methoxycinnamate, butyl methoxydibenzoylmethane, 2-hydroxy- 4-methoxy-benzophenone, and mixtures thereof. Substantially similar results are obtained If the naproxen is replaced, in whole or in part, with hydrocortisone acetate, lbuprofen, flufenamic acid, mefenamic acid, meclofenamic acid, piroxicam, felbinac, 4- (4'-pentyn-3'-one)-2,6 -di-t-butylphenol, -2,6-di-t-butylphenol, hexynoyl-2,6-di-t-butylphenol, 4-(R)-(+)-3'-methyl-5'-hexynoyl- 2,6-d-t-butylphenol, ,3"-dimethoxy propionyl)-2,6-dl-tbutylphenol, Manjistha, Guggal, and mixtures thereof. EXAMPLE VIII A suntan oil is prepared by combining the following components utilizing conventional mixing techniques. Component Percent by Weight of Composition Sesame Oil Cyclomethicone 20.0 Isopropyl Myrlstate BHA 0.05 Sorbitan Oeate Octyl Dimethyl PABA Propylparaben 0.7 Tocopherol Sorbate 2.00 ,tit 35 MIneral Oil q.s. II 4 IE 14 51 This suntan oil is useful for topical application to inhibit j damage caused by acute or chronic UV exposure. Use of an i amount of oil sufficient to deposit about 0.5 mg/cm 2 of tocopherol sorbate, and about 0.5 mg/cm 2 of the sunscreening agent to the skin Immediately prior to UV exposure is appropriate. Substantially similar results are obtained if the oil is applied to the skin up to 4 hours prior to UV exposure or up to 30 minutes after UV exposure. Substantially similar results are obtained if the octyl dimethyl PABA is replaced, in whole or in part, with 2-ethylhexyl p-methoxyclnnamate, butyl methoxydibenzoylmethane, 2-hydroxy- 4-methxybenzophenone, and mixtures thereof. 1 EXAMPLE IX A moisturizing oilrn-water-in-silicone sunscreen emulsion lotion is formed from the toilowing ingredients, Ingredient Percent by Weight Aqueous Phase: of Composition Purified Water 57.17 c Pantethine, 80% aq. soln. (humectant) 0.10 i 20 Methylparaben 0.20 Carbomer viscosity control agent (commercially 0,10 i available in the Acrltamer series from R.I.T.A. Corp.) Glycerin 2.50 Sodium alkyl polyether sulfonate (anionic 0.10 I emulsifier) Oil Phase: Heavy mineral oil 1,75 Cholesterol 1.00 Cetyl palmitate 0.20 PEG-22/Dodecyl glycol copolymer 0.20 S Ethylparaben 0.10 Propylparaben 0.15 Neutralizer Base: a 35 Triethanolamlne 0.10 Color Fragrance: FD&C Red No. 4 aq. soln.) 0.03 52 Odorant Oil 0.30 Silicone Phase: Cyclomethicone/Dimethicone copolyol (90:10) 9.50 Cyclomethicone/Dimethiconol (13:87) 5.00 Cyclomethicone 3.00 Phenyl Dimethicone 1.00 Pareth-15-3 (polyethylene glycol ester of a 2.00 mixed synthetic C 1 1 -C 1 5 fatty alcohol, av=3 moles EO) Octyl Methoxycinnamate 7.00 Benzophenone-3 0.50 Naproxen 2,00 Tocopherol Sorbate 2,00 C 1 2 15 Alcohols Benzoate 2.85 In a suitably sized vessel equipped with a suitable mechanical stirrer (Tekmar Model RW-20 stirring motor, manufactured by IKA-WERK, Germany), the water, pantethine, methylparaben, glycerine and sulfonate emulsifier are heated to about 72-75°C and mixed. Stirring is increased until a vortex forms in the aqueous solution. The thickener, Carbomer, Is slowly added to the vortex and allowed to mix until completely hydrated and the resultant gel solution is free of gelatinous particles and is uniform in composition, The temperature is maintained at about 72-75 0 C with constant agitation. The oil phase ingredients are added to a separate suitably sized vessel and heated to about 80-85 0 C using slow mechanical stirring once the oil phase becomes molten. At this point the sunscreening agents, naproxen and tocopherol sorbate are mixed In. When molten, agitation Is maintained to keep the oil phase uniform during heating. The heated oil phase Is then slowly added to the heated water phase with stirring to form the oil-in-water emulsion. After addition is complete, the mechanical stirring means is slowed to avoid unnecessary aeration of the emulsion and mixing Is 35 continued for approximately fifteen minutes at 70-75°C, The emulsion Is then cooled to about 600C with moderate agitation. The base, triethanolamine, is then slowly added to neutralize the 53 acidic Carbomer 940 and the emulsion (pH 6.5) is mixed at moderate speed until uniform. The homogeneous oil-in-water emulsion is then cooled to about 45-50°C and the colorant and odorant oil are added followed by cooling to room temperature (about 25 0 C) with continued moderate agitation. The four silicone fluids and other silicone phase ingredients i are mixed together in a separate vessel until a uniform silicone phase is attained. The oil-in-water emulsion is slowly added tc Sthe silicone phase with stirring until a homogeneous oil-inwater-in-silicone double emulsion in lotion form is attained. 1 This moisturizing lotion is useful for topical application to 1 inhibit damage caused by acute or chronic UV exposure. Use of an amount of lotion sufficient to deposit about 0.5 mg/cm 2 of tocopherol sorbate, about 0.5 mg/cm 2 of sunscreening agents, and 15 about 0.1 mg/cm 2 of naproxen to the skin Immediately following UV exposure is appropriate. Substantially similar results are I obtained if the lotion is applied to the skin up to 30 minutes after UV exposure or up to 4 hours prior to UV exposure. This lotion may also be applied several times dally, 2 or 3 times daily, for extended periods of time, greater than one week, in amounts sufficient to deposit about 0.5 mg/cm 2 of tocopherol i{ sorbate, about 0.5 mg/cm 2 of sunscreening agents, and about 0.1 mg/cm 2 of naproxen to the skin to inhibit damage caused by chronic UV exposure. Substantially similar results are obtained If the octyl methoxycinnamate and benzophenone-3, are replaced, in whole or in part, with 2-ethylhexyl p-methoxycinnamate, butyl methoxydibenzoyl methane, 2-hydroxy-4-methoxybenzophenone, and mixtures thereof. Substantially similar results are obtained If the naproxen Is replaced, In whole or In part, with hydrocorti sone acetate, lbuprofen, flufenamic acid, mefenamic acid, meclofenamic acid, piroxicam, felbinac, 4- (4 1 -pentyn-3 1 -one)-2,6-di-t-butylphenol, 4-(5'-hexynoyl -2,6-d-t-butylphenol, 4-(S)-(-)-3!-methylS- 35 hexynoyl-2,6-dl-t-butylphenol, 4-(R)-(+)-3-methyl-5'-hexynoyl- 2,6-di-t-butylphenol, i-(3',3'-dimeth yproplonyl )-2,6-di-tbutylphenol, Manjistha, Guggal, and mixtures thre,,of. LuI IIe y Ved Uer Lldfl buvtvI Pi ~I UI aIM I Y 9i L L4 I Prefraby tis egien of application is continued for as long as the user chrncly xoe him or herself to damaging UV rat 'tion. This may -coimprise application over a period of several 54- EXAMPLE X A skin conditioning toilet bar is prepared from the following ingredients. Component Percent by Weight of Comp osition Tallow/Coconut Soap (50/50) 61.61 Water100 2Hydroxypropylglyceryl Ethelfo t 4.00 Sodium Coconut Glyceryl Ether Sloae88 Coconut Fatty Acid (CnFA) 4.00 Tocopherol Sorbate Perfume 1 NaCI 1 .04 Na 2 so 4 0.34 Na 4 EDTA 0.06 TiO 2 0.20 Jaguar C15 (quar hydroy'y propyltrmonium I.00 chlorlde) Merquat 550 (poly quaterrilum-7) 1.00 Minori (Colorants, Preservatives, Fillers, etc.) 1.55 The above composition Is prepared In the -following manner. Crutching Step About 127.6 parts of a mix containing: 29.8% water, 52,7% 50/50 tallow/coconut (T/Cn) soap, 16.7% sodium coconut glyceryl, ether sulfonate paste, 3.3% coconut free fatty acid (CnFA), 3.1% 2-hydroxypropylglycf:.ryl ether, and 0.2% NaCI are heated to ca. 150-200OF (65-'94 0 C) About 10. parts of the hydrated polymer JAG!.AR C-15 are mixed in, T Ihe tocopherol sorbate, is then added and mixld In, Vacuum Drying, Step The crutcher mix Is vacuum drlz-d at ca. 50 mmr H-g absoluio pressure to reduce the moisture content of the mix to ca. and to plod this soap Into noodles. These noodles are passed through a milling step once. conjunction with UV exposure, prior to, concommitantly with, or after UV exposure. More specifically, the combination S may be applied up to about 4 hours prior to UV exposure, up to I f Amalgamating Step The once-milled soap noodles are weighed and placed in a batch amalgamator. To about 99.1 parts noodles in the amalgamator are added: 0.20 part TIO2, 14 parts perfume, 0.15 part colorant solution, 0.15 part of a solution which contains ca. EDTA. The combined Ingredients are mixed thoroughly. Milling Step Three-roll soap mills are set up with all rolls at 85-105OF (29-41°C). The mixture from the amalgamator is passed through the mills several times to obtain a homogeneous mix. This is an intimate mixing step. Ploddlng and Stamping Steps A conventional plodder is set up with the barrel temperature at about 90 9 F (32 0 C) and the nose temperature at about 10 0 °F (43 0 The plodder used is a dual stage twin screw plodder that allows for a vacuum of about 40 to 65 mm Hg between the two stages. The soap log extruded from the plodder is typically round or oblong in cross-section, and is cut into individual plugs. These plugs are then stamped on a conventional soap i i .20 stamping apparatus to yield the finished toilet soap bar. SThe use of this toilet bar for cleansing provides a useful eans for deposition of tocopherol sorbate to the skin to inhibit' damage catused by acute or chronic UV exposure. Use of the', toilet bar such that about 0.05 mg/cm 2 of tocopherol sorbate is deposited on the skin immediately p or to UV exposure is appropriate. Substantlaily similar .su' s are obtained if the toilet bar is used up to 4 hours prior JV exposure or up to minutes after UV exposure. EXAMPLE XI Facial Cleanser S. A facial cleanser (lathering mousse composition) is prepared from the following Ingredients. Emulsion Concentrate Percent by Weight of Composition DRO Water 52.63 2-Hydroxypropyglyceryl Ether 15.00 56 Sodium Glyceryl Ether Sulfonate Coconut/10 Tallow)-50% Active Sodium Lauroyl Sarcosinate 33% Active PEG 600 Aloe Vera Gel Lexein LP170P (hydro!yzed animal protein) Stearic Acid Citric Acid Tocopherol Sorbate Jaguar C14-S (guar hydroxypropyltrimonium 12.06 6.66 4.00 1.00 1.00 1.00 0.30 5.00 0.25 t S E chloride) Perfume 0.20 FDEC Red Dye #4 0.20 Lauryl Alcohol 0.20 Alkyl Parabens 0.30 Germall 115 (Imidazolidinyl urea) 0.10 Na EDTA 0.10 11; Water purified by double reverse osmosis A-46 Propellant (Isobutane-Propane) (B) (6.4g In 100g concentrate) The composition is prepared In a single batch process. DRO water is brought to 71.1°C and the Jaguar polymer is added with' agitation. Maintaining agitation, the following ingredients ared added sequential!y: Sodium glycerol ether sulfonate, Sodium lauroyl sarcosinate, lauryl alcohol, PEG-600, Parabens, EDTA, dye, 2-Hydroxypropylglyceryl ether, stearic acid, Aloe Vera Gel, citric acid and tocopherol sorbate. The mixture is then cooled to 135-140 0 F and the following Ingredients are added sequentially with stirring: Lexein, Germall and perfume. The resulting mixture Is cooled to room temperature. S Aluminum cans are then filled with the cooled emulsion S concentrate. Aerosol activator assemblies are then crimped onto the cans to form a tight sea.l Pressurized A-46 Propoliant is then pumped Into the cans in an amount sufficient to provide a S 35 composition consisting of 6% propellant and 94% emulsion concentrate in each can. (gC Glyceryl Stearate U. Polyoxyethylene Stearyl Alcohol (commercially 1.75 available in the Brij series from ICI Americas, Inc.) 1 57 Upon activation of the aerosol assembly, the composition is dispensed under pressure in the form of a creamy, foaming mousse which can be applied to the skin for cleansing and as a means for deposition of tocopherol sorbate to the skin to inhibit damage caused by acute or chronic UV exposure. Use of amount of facial cleanser sufficient to deposit about 0.05 mg/cm 2 of S tocopherol sorbate to the skin immediately prior to UV exposure is appropriate. Substantially similar results are obtained if the I cleanser is used up to 4 hours prior to UV exposure or up to minutes after UV exposure. EXAMPLE XII A cream soap is prepared by combining the following ingredients as described below. Component Percent by Weight 1 8 of Composition Sodium Lauroyl Clutamate (Acylglutamate LS-11) (28) 22.00 Sodium Hydrogenated Tallow Glutamate and Cocoyl Glutamate (Acylglutamate CS-11) (28) 3.00 Polyethylene Glycol 400 10.00 Polyethylene Glycol 6360, Monostearate 5.00 Polyoxyethylene (20) Sorbitan Monostearate 3.00 SI Tocopherol Sorbate 5.00 i Flufenamic Acid 5.00 2-Ethylhexyl Methoxycinnamate 3.00 Water 33.50 Glycerin 10.00 Fragrance and Preservative q.s. The sodium glutamate, sodium hydrogenated tallow glutamate V 30 and cocoyl glutamate, polyethylene glycol, polyethylene glycol monostearate, polyoxyethylene sorbitan monostearate, tocopherol J sorbate, flufenamic acid, 2-ethylhexyl methoxycinnamate, and water are dissolved together with heating. The glycerin is added with agitation. The mixture is cooled to about 600C and the fragrance and preservative are added. The mixture is cooled to 0 C with agitation. a I to ijoenzoyi Metane Water (purified) 35 Dimethyl Isosorbide Dioctyl Maleate C 12 -1 5 Alcohol Benzoate (Finsolv TN-commercially 47.54 8.00 8.00 8.00 c_ 58 The result is a cream soap the use of which for cleansing provides a useful means for deposition of tocopherl sorbate, flufenamic acid, and 2-ethylhexyl methoxycinnamate to the skin to inhibit damage caused by acute or chronic UV exposure. Use of an amount of cream soap sufficient to deposit about 0.05 mg/cm 2 of tocopherol sorbate, 0.05 mg/cm, of the sunscreening agent, and 0.01 mg/cm 2 of flufenamic acid to the skin immediately following UV exposure is appropriate. Substantially similar results are obtained if the soap is used up to 30 minutes after UV exposure or up to 4 hours prior to UV exposure. Substantially similar results are obtained if the 2-ethyihexyl methoxycinnamate is replaced, in whole or in part, with octyl methoxycinnamate, butyl methoxydibenzoylmethane, 2-hydroxy-4methoxybenzophenone, and mixtures thereof. Substantially similar results are obtained if the flufenamic acid is replacud, in whole or in part, with hydrocortisone acetate, ibuprofen, naproxen, mefenamic acid, meclofenamic acid, piroxicam, felbinac, 4-(4'-pentyn-3'-one) 6-di-t-butyl Iphenol, hexynoyl -2 6-di-t-butylphenol, S) 2,6-di-t-butylphenol, 4-(R)-(+)-3'--iethyl-5'-hexynoyl-2,6-di-tbutylphenol, ,3'-dimethoxypropionyl-2,6-di-t-butylphenol, Manjistha, Guggal, and mixtures thereof, EXAMPLE Xll'd A shampoo composition is made by combining the following components. Component Percent by Weight Ammonium Lauryl Sulfate Ammonium Xylene Sulfonate Ammonium Laureth Sulfate NaCI Tocopherol Sorbate Octyl Dimethyl PABA Water 35 Perfume and Minor Ingredients of Composition 12.0 2.2 4.0 68.1 1.2 I C t iI S- 59- I The ammonium lauryl sulfate, ammonium laureth sulfate, and ammonium xylene sulfonate are first mixed together. The tocopherol sorbate and octyl dimethyl PABA and perfume and minor ingredients are added and the resulting mixture is agitated R in a Teckmar Mill set at 70 for 2 minutes at 70 0 C. The resulting shampoo composition is added to hair which has been wetted with water, worked through the hair then rinsed ov', This allows for deposition of tocopherol sorbate and octyl dimethyl PABA to the scalp to inhibit damage caused by acute or chronic UV exposure. Use of an amount of shampoc sufficient to deposit about 0.05 mg/cm 2 of tocopherol sorbate and 0.05 mg/cm 2 of sunscreering agent to the scalp Immediately following UV exposure is appropriate. Substantially similar results are obtained if the shampoo is used up to 30 minutes after or up to 4 hours prior to UV exposure. Substantially similar results are obtained if the octyl dimethyl PABA is replaced, in whole or in part, with 2-ethylhexyl methoxycinnamate, butyl methoxydibenzoylmethane, 2-hydroxy- 4-methoxybenzophenone, octyl methoxycinnamate, and mixtures thereof. Substantially similar results are obtained if the flufenamic acid is replaced, in whole or in part, with hydrocortisone acetate, SIbuprofen, naproxen, mefenamic acid, meclofenamic acid, piroxi-, cam, felblnac, 4-(4'-pentyn-3'-one)-1 ,6-di-t-butylphenol, 4-1(5'hexynoyl)-2,6-di-t-butylphenol, 2,6-di-t-butylphenol, R)-(+)-3'-methyl-5'-hexynoyl-2,6-di-tbutylphenol, 3'-dimethoxypropionyl)-2,6-di-t-butylphenol, Manjistha, Guggal, and mixtures thereof. 4 Claims (29) 1. A composition useful for topical application comprising a safe and photoprotectively effective amount of tocopherol sorbate and a safe and effective amount of a topical carrier wherein the the tocopherol sorbate is present in an amount of not more than about 25% weight. 2. The composition of claim 1 which comprises from about 1% to about 10% of tocopherol sorbate. 3. The composition of claim 2 which comprises from about 1% to about 5% of tocopherol sorbate. 4. The composition of claim 2 which comprises from about 85% to about 99" of the carrier. The composition of claim 4 which is in the form of a solution. 6. The composition of claim 5 which additionally comprises a thickening agent in an amount sufficient to form a gel. 7. The composition of claim 5 which additionally comprises a propellant in an amount sufficient to form an aerosol spray. 8, The composition of claim 4 wherein the carrier comprises an emollient. 9. The composition of claim 8 wherein the emollient is selected from the group consising of hydrocarbon oils and waxes, silicone oils, triglycride esters, acetoglyceride -1.54/Diok iSI/c.C. I I I V 61 esters, ethoxylated glycerides, alkyl esters of fatty acids, alkenyl esters of fatty acids, fatty acLdq, fatty alcohols, fatty alcohol ethers, fatty acid esters of ethoxylated fatty alcohols, ether-esters, lanolin and its derivatives, polyhydric alcohols, and polyeth'z derivatives, vegetable waxes, phospholipids, sterols, amides, and mixtures thereof. The composition of claim 8 wherein the emollient is glycerol. 11. The composition of claim 8 containing from about 1% to about 10% by weight of an emollient which comprises a propoxylated glycerol derivative having the formula: OH OH CH 3 CH 2 CH CH 2 (OCH 2 CH)OH, ft *f t I I II I I t I II OH H CH LH H CH 2 (OH CH 2 )nOH, I t Li [I I I OH OH CH CH CH H CH CH CH CH OH, and OH OH CH3 CH 3 CH C CCH 2 CH CH 2 0- CH CH OH, wherein n 1 or 2, and mixtures thereof. 12. The composition of claim 4 which is in the form of an emulsion. 1. 54/DiLBk f (1 I t I It 4 4 62 13. The composition of claim 12 wherein the emulsion comprises from about 1% to about 10% by weight of an emulsifier. 14. The composition of claim 13 wherein the emulsifier is an organic nonionic surfactant. The composition of claim 12 which is formulated as a lotion. 16. The composition of claim 12 which is formulated as a cream. 17. Ths composition of claim 4 which is formulated as a cosmetic foundation. 18. The composition of claim 4 which is formulated as a lipstick. 19. A skin cleaning composition of claim 1 wherein the carrier comprises from about 5% to about 80% of a cosmetically-acceptable surfactant. The composition of claim 19 wherein the surfactant is anionic and is selected from the gruup consisting of soaps, alkyl glycerol ether sulfonates and mixtures thereof. 21. The composition of claim 19 which is in the form of a bar soap. 22. The i.mposition of claim 19 which is in the form of a liquid soap. 1.54/Disk 151/C Ii -63- 23. The composition of claim 19 which is in the form of a paste. 24. The composition of claim 19 which is in the form of a mousse. The composition of claim 4 wherein the carrier comprises an oil-in-water-in-silicone fluid emulsion composition comprising: from about 15% to about 90% by weight of the I qo emulsion composition of a silicone fluid continuous phase 0 consisting essentially of at least one liquid organopolysiloxane; S' from about 30% to about 80% by weight of the S emulsion composition of an aqueous discontinuous phase comprising an oil-in-water emulsion of a cosmetically-acceptable oily liquid non-particulate phase dispersed in an aqueous phase; and from about 0.5% to about 5% by weight of the ti, emulsion composition of an effective dispersing amount of dimethicone copoiyol for dispersing in 26. The composition of claim 4 which additionally j comprises from about 0.25% to about 3% of an ethylene acrylic acid copolymer having the formula j( CH )(CH2 CH)(CH H)y I OH IM J wherein the ratio of x:y is from about 1:9 to about 1:24 and the molecular weight of the copolymer is from about 3500 to about 4500. I.54/Disk 151/C.C. 64 27. The composition of claim 4 which additionally comprises a safe and effective amount of a penetration enhancer. 28. The composition of claim 4 which additionally comprises a safe and photoprotectively effective amount of a sunscreening agent. 29. The composition of claim 28 which comprises from about 1% to about 10% of the sunscreening agent. TbO~ composition of claim 29 wherein the su.nscreening agent is selected from the group consisting of 2-ethylhexyl p-methoxycinnamatet butyl methoxydibenzoyl- methane, 2-hydroxy-4-methoxybcnzophenone, octyl dimethyl p-aminobenzoic acid, the 4-N,WN-(2-ethylhexyl)methylamino- benzoic acid ester of 2,4-dihydroxybenzophenone, the NN-di-(2-ethylhexyl)-4-aninobenzoic acid ester of 4-hydroxydibenzoylmethane, the 4-NN-2-ethylhexyl)methyl- aminobenzoic acid ester of 4-hycdroxy-di-benzoylmethane, the 4-W,N-(2-ethylhexyl)methylaminobenzoic acid ester of 2- hydroxy-4-(2-hydroxyethoxy) benzophenone, the ethylhexyl)methylaminobenzoic acid ester of 4-(2-.hydlroxy- ethoxy)dibenzoylmethane, the N-N-'di-(2-ethylhex~yl)-4- aminobenzoic acid ester of 2-hydroxy-4-(2-hydroxyethoxy)- benzop Ihenoneo the NN-di(2-ethylheXyl)-4-aminobenzoic acid ester of 4-(2-hydroxyetho,~y)dibenzoylmethane and mixtures thereof. 31, The composition of claim 26 which additionally comprises a sunscreening agent selected from the grotiP consisting of 2-ethyliexyl p-iuethoxycinnomate, butyl methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoic acid aind mixtures thereof. 32. A method of inhibiting the deleterious effects of ultraviolet light exposure to skin comprising applying a safe and photoprotectively effective amount of tocopherol sorbate to the skin in conjunction with exposing the skin to ultraviolet light. 33. The method of claim 32 wherein from about 0.01 Mgq2 M/12 t mg/cm to about 1.0 mg/c1 of tocopherol sorbate is applied to the skin. 34. The method of claim 33 wherein from about 0,05 mg/cm 2 to about 0.5 mg/cm 2 of tocopherol sorbate is applied to the skin, A method of inhibiting the deleterious effectS of ultraviolet exposure to skin comprisin applyin9 a sae and photoprotectively effective amount of tocopherol sQrbate and a safe and photoprotectively effective amount of a sunscreening agent to the skin simultaneously in conjunction with Uv exposure. 36. The method of claim 35 wherein from about 0.01 g/cm' to about 1.0 mg/cml tocopherol sorbate and from about 0.01 mg/m2 to about 1,0 mg/zmo of the sunocreening agent is applied to the skin. 37. The method of claim 36 wherein from about 0-05 mg/cm to about 0.5 mg/cmi tocopherol sorbate and from about 0.05 mg/cm 2 to about 0.5 mg/cm 2 of the sunscreening agent is applied to the okin, 38. The method of claim 37 wherein the sunscreening agent is selected from the group consisting of 2-ethythexyl p-methoxyinnamate, butyl methoxydibenzoy1methane, 1,54/iak ibi/rCI Aa t -9 t -66- 2-hydroxy-4-methoxybenzophenone, octyl dimethyl p-amino- benzoic acid, the 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester of 2,4-dihydroxybenzophenonef the N,N-cli-(2- ethylhexyl)-4-aminobenzoic acid ester of 4-Chydroxy- dibenzoylmethanef the 4-N,N-(2-ethylhexyl~methylamino- benzoic acid ecter of 4-hydroxydi-benzoylmethane, the 4-N,N-(2-ethylhexyl)methylamiiobeizoic acid ester of 2- hydroxy-4-(2-hydroxyethoxy)benzophenone, the etyhxlmtyamntnocai ester of 4-(2-hydroxy- dibenzoylmethane, the N-t1-di-( 2-ethylhexyl)-4-aminobenzoic acid ester of 2-hydroxy-4--(2-hydroxye-thoxy)benzophenone, the N,NI-di--(2-ethyl-hexyl)-4-aminobenzoic acid ester of 4-(2- hydroxy-ethoxy)dibenzoylrdethane and miixtures thereof. 39, The method of claim 32 wherein tetocopherol sorbate is applied to the skin up to about 4 houre prior to UV exposure, The method of claim 35 wherein the tocopherol sorbate and the sunscreening agent are applied to the skin up to about 4 hours, prior to UJV exposure. DATED this lot day of Novet 1 ber, 1990. II THE PROCTER GAMBL8 COMPANY WATERMARK~ PATENT& TRADE MARK ATTORNEYS OTH8E ATRIUM'# 2ND FLOOR 290 gUAlWOOD ROAD HAWTHORN VIC. 31.22. AU24083/88A 1987-10-22 1988-10-21 Photoprotection compositions comprising tocopherol sorbate Ceased AU607101B2 (en) Applications Claiming Priority (2) Application Number Priority Date Filing Date Title US112574 1980-01-16 US07/112,574 US4847072A (en) 1987-10-22 1987-10-22 Photoprotection compositions comprising tocopherol sorbate Publications (2) Publication Number Publication Date AU2408388A AU2408388A (en) 1989-04-27 AU607101B2 true AU607101B2 (en) 1991-02-21 Family ID=22344653 Family Applications (1) Application Number Title Priority Date Filing Date AU24083/88A Ceased AU607101B2 (en) 1987-10-22 1988-10-21 Photoprotection compositions comprising tocopherol sorbate Country Status (9) Country Link US (1) US4847072A (en) EP (1) EP0313304B1 (en) JP (1) JP2812690B2 (en) KR (1) KR0131461B1 (en) AT (1) ATE84703T1 (en) AU (1) AU607101B2 (en) CA (1) CA1328409C (en) DE (1) DE3877690T2 (en) NZ (1) NZ226666A (en) Families Citing this family (76) * Cited by examiner, † Cited by third party Publication number Priority date Publication date Assignee Title US4814165A (en) * 1987-03-03 1989-03-21 Kolmar Laboratories Inc. Emulsified hydrated stick product US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid US5039513A (en) * 1987-10-22 1991-08-13 The Procter & Gamble Company Photoprotection compositions and methods comprising sorbohydroxamic acid US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease US5444096A (en) * 1989-06-02 1995-08-22 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor CA2014633C (en) * 1989-06-02 2000-07-18 Andrew D. Mccrea Stable anhydrous compositions for topical delivery of active materials CA2069864A1 (en) * 1989-12-04 1991-06-05 Rupali A. Kulkarni Photoprotective compositions WO1991016914A1 (en) * 1990-05-07 1991-11-14 Bockow Barry I Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof EP0532703A4 (en) * 1990-06-08 1993-05-26 Affinity Biotech, Inc. Process for preparing microemulsion GB9021320D0 (en) * 1990-10-01 1990-11-14 Diomed Dev Ltd Compositions for topical application JPH04261111A (en) * 1991-02-13 1992-09-17 Kanebo Ltd W/o-type emulsion cosmetic US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same US5692302A (en) * 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same US5614561A (en) * 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same US5373028A (en) * 1991-08-20 1994-12-13 The Dow Chemical Company Polyurethane foams having reduced visible emissions during curing US5270430A (en) * 1991-11-13 1993-12-14 The Dow Chemical Company Polymers stabilized with 6-chromanol derivatives US5218008A (en) * 1991-11-13 1993-06-08 The Dow Chemical Company Polyethers stabilized with 6-chromanol derivatives US5494657A (en) * 1992-04-30 1996-02-27 Swenson; Russell H. Skin care formulation DK0656773T3 (en) * 1992-08-26 1997-10-13 Univ Leiden Use of radical scavengers as immunomodulatory agents in cosmetic and dermatological preparations. DE4342719A1 (en) * 1993-12-15 1995-06-22 Beiersdorf Ag Cosmetic or dermatological O / W emulsions containing amino acid and inorganic pigments US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions US5739156A (en) * 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells US5922758A (en) * 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin DE29511484U1 (en) * 1995-07-15 1995-10-05 Basf Ag Light protection agents containing p-methoxycinnamate US5707612A (en) * 1996-04-08 1998-01-13 Alzo, Inc. Use urethane polymers of castor oil skin and personal care product compositiions US5747010A (en) * 1996-06-12 1998-05-05 Johnson & Johnson Consumer Products, Inc. Photoprotective lipophilic antioxidant compounds and their use to prevent UVA-mediated lipid peroxidation AU6150198A (en) * 1997-02-11 1998-08-26 Procter & Gamble Company, The Skin lightening compositions DE19710149A1 (en) * 1997-03-12 1998-09-17 Henkel Kgaa Body cleanser US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting DE19750528A1 (en) * 1997-11-14 1999-05-20 Basf Ag Ascorbylsorbate US6329330B1 (en) * 1998-06-01 2001-12-11 Johnson & Johnson Consumer Companies, Inc Photostable compositions US6217852B1 (en) 1998-08-15 2001-04-17 Skinnovative Dermatologic Concepts, L.L.C. Personal cleansing compositions having photoprotective agents US6355280B1 (en) * 2000-02-28 2002-03-12 I.M.S. Cosmetics Composition for reducing cell apoptosis containing avocado and soybean lipid unsaponifiables DE10048260A1 (en) * 2000-09-29 2002-04-11 Beiersdorf Ag Cosmetic or dermatological composition for combating undesirable skin pigmentation, contains aminoguanidine or its derivatives DE10053328A1 (en) * 2000-10-27 2002-05-08 Cognis Deutschland Gmbh Cosmetic preparations WO2004050045A1 (en) * 2002-12-04 2004-06-17 Dow Corning Corporation Vesicle and microemulsion compositions of polar organic oils based on silicone surfactants AU2003295159A1 (en) * 2002-12-24 2004-07-22 Oxonica Limited Sunscreens US20060112503A1 (en) * 2004-11-29 2006-06-01 The Procter & Gamble Company Solid personal care composition US20060182828A1 (en) * 2005-02-17 2006-08-17 Colman John S Methods of reducing lipid peroxidation and achieving related health benefits by the administration of tocopherol and sesame lignans US8222192B2 (en) * 2009-06-19 2012-07-17 R&W Medical LLC Alcohol-based skin cleanser US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use KR20130070608A (en) 2010-05-10 2013-06-27 세게티스, 인코포레이티드. Alkyl ketal esters as dispersants and slip agents for particulate solids, methods of manufacture, and uses thereof US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin DE102011119373A1 (en) 2011-11-25 2013-05-29 Heraeus Quarzglas Gmbh & Co. Kg Process for the production of synthetic quartz glass DE102011119339A1 (en) 2011-11-25 2013-05-29 Heraeus Quarzglas Gmbh & Co. Kg Sputtering process for the production of synthetic quartz glass DE102011119341A1 (en) 2011-11-25 2013-05-29 Heraeus Quarzglas Gmbh & Co. Kg Process for the production of synthetic quartz glass using the soot method DE102011119374A1 (en) 2011-11-25 2013-05-29 Heraeus Quarzglas Gmbh & Co. Kg Process for the production of synthetic quartz glass WO2014085609A1 (en) 2012-11-29 2014-06-05 Segetis, Inc. Carboxy ester ketals, methods of manufacture, and uses thereof JP5985429B2 (en) * 2013-03-27 2016-09-06 第一工業製薬株式会社 Liquid detergent composition WO2017080758A1 (en) * 2015-11-10 2017-05-18 Unilever Plc Cyclocarboxylic acid containing personal care compositions Citations (2) * Cited by examiner, † Cited by third party Publication number Priority date Publication date Assignee Title US4144325A (en) * 1976-11-10 1979-03-13 Voyt Walter F Method of and composition for preventing sunburn while affording tanning AU576863B2 (en) * 1984-05-29 1988-09-08 Henkel Corporation Sunscreen composition containing tocopherol ester Family Cites Families (6) * Cited by examiner, † Cited by third party Publication number Priority date Publication date Assignee Title US4248861A (en) * 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone US4663157A (en) * 1985-02-28 1987-05-05 The Proctor & Gamble Company Sunscreen compositions US4847267A (en) * 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method EP0281394A3 (en) * 1987-03-06 1990-05-16 Richardson-Vicks, Inc. Oil-in-water-in-silicone emulsion compositions 1987 1987-10-22 US US07/112,574 patent/US4847072A/en not_active Expired - Lifetime 1988 1988-10-18 DE DE8888309740T patent/DE3877690T2/en not_active Expired - Fee Related 1988-10-18 EP EP88309740A patent/EP0313304B1/en not_active Expired - Lifetime 1988-10-18 AT AT88309740T patent/ATE84703T1/en not_active IP Right Cessation 1988-10-20 CA CA000580802A patent/CA1328409C/en not_active Expired - Fee Related 1988-10-21 AU AU24083/88A patent/AU607101B2/en not_active Ceased 1988-10-21 NZ NZ226666A patent/NZ226666A/en unknown 1988-10-22 JP JP63267016A patent/JP2812690B2/en not_active Expired - Fee Related 1988-10-22 KR KR1019880013862A patent/KR0131461B1/en not_active IP Right Cessation Patent Citations (2) * Cited by examiner, † Cited by third party Publication number Priority date Publication date Assignee Title US4144325A (en) * 1976-11-10 1979-03-13 Voyt Walter F Method of and composition for preventing sunburn while affording tanning AU576863B2 (en) * 1984-05-29 1988-09-08 Henkel Corporation Sunscreen composition containing tocopherol ester Also Published As Publication number Publication date KR890006213A (en) 1989-06-12 CA1328409C (en) 1994-04-12 EP0313304A2 (en) 1989-04-26 DE3877690T2 (en) 1993-05-27 KR0131461B1 (en) 1998-04-17 AU2408388A (en) 1989-04-27 EP0313304B1 (en) 1993-01-20 JP2812690B2 (en) 1998-10-22 NZ226666A (en) 1991-07-26 JPH01265014A (en) 1989-10-23 ATE84703T1 (en) 1993-02-15 US4847072A (en) 1989-07-11 EP0313304A3 (en) 1989-08-09 DE3877690D1 (en) 1993-03-04 Similar Documents Publication Publication Date Title AU607101B2 (en) 1991-02-21 Photoprotection compositions comprising tocopherol sorbate EP0313303B1 (en) 1994-04-27 Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent US5384115A (en) 1995-01-24 Photoprotection compositions comprising a radical scavenging compound and an anti-inflammatory agent US4847069A (en) 1989-07-11 Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent US4869897A (en) 1989-09-26 Photoprotection compositions comprising sorbohydroxamic acid EP0496433B1 (en) 1999-03-24 Photoprotection compositions comprising chelating agents US5039513A (en) 1991-08-13 Photoprotection compositions and methods comprising sorbohydroxamic acid US4946671A (en) 1990-08-07 Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent US5439954A (en) 1995-08-08 Substituted phenyl-1,3-diketones as protectants against skin damage WO1995001157A1 (en) 1995-01-12 Use of hydroxyphenyl oximes as chelating photoprotectants EP0746306B1 (en) 2001-11-07 Benzoylacetate esters as non-sensitizing chelating photo-protectants US5456904A (en) 1995-10-10 Photoprotection compositions comprising certain chelating agents
Download PDF in English